Endocrine Abstracts

Contents

• Prize Lectures and Biographical Notes
• • The European Journal of Endocrinology Prize Lecture
  • • Regulation of aldosterone secretion: from physiology to disease

      ea0032eje1
    • The European Journal of Endocrinology Prize Winner

      ea0032eje1biog
  • The Geoffrey Harris Prize Lecture
  • • Speakers, cross-talk and chatter in reproductive neuroendocrinology

      ea0032gh1
    • The Geoffrey Harris Prize Winner

      ea0032gh1biog
• Plenary Lectures
• • Nutrient-sensing pathways in ageing
  • • Nutrient-sensing pathways and ageing

      ea0032pl1
  • NET Management
  • • Neuroendocrine tumour management

      ea0032pl2
  • Changing character of thyroid cancer
  • • Changing character of thyroid cancer

      ea0032pl3
  • Fondation IPSEN 2013 Endocrine Regulations Prize
  • • Nuclear receptor 'master' coactivators of physiology and pathology

      ea0032pl4
  • Preventing vascular complications of diabetes
  • • Prevention and treatment of renal and cardiovascular disease in diabetes: new aspects

      ea0032pl5
  • The Ubiquitin System
  • • Abstract unavailable

      ea0032pl6
  • Aldosterone, Mineralocorticoid Receptors and Cardiovascular Risk: What's New?
  • • Aldosterone, mineralocorticoid receptors and cardiovascular risk: what's new?

      ea0032pl7
  • New genes and functions in reproduction
  • • New genes and functions in reproduction

      ea0032pl8
  • Human Brown Fat is on Fire
  • • Human brown fat is on fire

      ea0032pl9
• Symposia
• • Metabolic surgery
  • • New insights in obesity pathophysiology of metabolic surgery

      ea0032s1.1
    • Abstract unavailable

      ea0032s1.2
    • Abstract unavailable

      ea0032s1.3
  • Cushing's Disease with negative pituitary imaging
  • • Abstract unavailable

      ea0032s2.1
    • Surgical approach to corticotroph adenomas poorly visible at preoperative imaging

      ea0032s2.2
    • Medical approach to Cushing's disease: results of a French multicentre study

      ea0032s2.3
  • Female reproduction
  • • The transcription factor FOXL2 in ovarian physiology and pathology

      ea0032s3.1
    • NR5A1/SF-1 and gonadal development and function

      ea0032s3.2
    • Progestin action in the brain

      ea0032s3.3
  • New advances in GPCRs in endocrinology
  • • Abstract unavailable

      ea0032s4.1
    • Biased agonism of the AT1 receptor: perspectives in drug discovery?

      ea0032s4.2
    • G-protein-coupled receptor heteromers as new targets for drug development

      ea0032s4.3
  • A guide through the labyrinth of neuroendocrine tumours
  • • Tumor biology and classification of NET

      ea0032s5.1
    • Nuclear medicine imaging of neuroendocrine tumours

      ea0032s5.2
    • Abstract unavailable

      ea0032s5.3
  • What's new in type 2 diabetes?
  • • The impact of our genomes on metabolic health

      ea0032s6.1
    • Insulin resistance and adipose tissue

      ea0032s6.2
    • Mechanisms of [beta] cell failure in type 2 diabetes

      ea0032s6.3
  • Translational aspects from comparative to clinical endocrinology
  • • Brain aromatase and endocrine disruptors in zebrafish: from basic to applied research

      ea0032s7.1
    • Abstract unavailable

      ea0032s7.2
    • Peptide hormones and receptors: why so many?

      ea0032s7.3
  • Action of glucocorticoids on bone
  • • Glucocorticoid action on the skeleton

      ea0032s8.1
    • Osteoporosis: now and the future

      ea0032s8.2
    • Glucocorticoid-induced osteoporosis

      ea0032s8.3
  • New data treatment of hyperglycemia
  • • GLP-1 analogues

      ea0032s9.1
    • Early insulin treatment in type 2 diabetes

      ea0032s9.2
    • Ultra-long acting insulins

      ea0032s9.3
  • Salt-water balance
  • • Abstract unavailable

      ea0032s10.1
    • Clinical aspects of diabetes insipidus and hyponatremia

      ea0032s10.2
    • Antidiuresis: insights into the molecular regulation

      ea0032s10.3
  • New mechanisms in SST analogue response
  • • Functional relevance of truncated SST5 receptor variants

      ea0032s11.1
    • Role of filamin A in dopamine and somatostatin receptor targeting in the pituitary

      ea0032s11.2
    • Role of ERK in somatostatin receptor signalling

      ea0032s11.3
  • Male reproductive endocrinology
  • • Semaphorin 3A: a new gene involved in Kallmann syndrome

      ea0032s12.1
    • Signal transduction in sperm functions

      ea0032s12.2
    • Small RNAs in spermatogenesis

      ea0032s12.3
  • Hormonal treatment in transition of patients with rare diseases (Supported by the European Journal of Endocrinology)
  • • Hormonal treatment in transition of patients with Prader-Willi syndrome

      ea0032s13.1
    • Transition of females with Turner syndrome

      ea0032s13.2
    • Hormonal treatment of patients with Klinefelter syndrome during transition

      ea0032s13.3
  • Clinical care of the pheochromocytoma patient
  • • Clinical care of the pheochromocytoma patient

      ea0032s14.1
    • Pheochromocytoma imaging

      ea0032s14.2
    • Treatment of malignant pheochromocytomas and paragangliomas

      ea0032s14.3
  • The Frail Male
  • • Sarcopenia in men: the endocrine perspective

      ea0032s15.1
    • Male osteoporosis

      ea0032s15.2
    • Cognitive decline in male ageing

      ea0032s15.3
  • Oncogenic signals in thyroid cancer - therapeutic prospects
  • • BRAF_V600E and PIK3CA_H1074R cooperate to promote progression of anaplastic thyroid carcinoma in the mouse

      ea0032s16.1
    • Abstract unavailable

      ea0032s16.2
    • Oncogenic activation in thyroid cancer and response to radioiodine

      ea0032s16.3
  • Medical treatment of endocrine malignancies - an update
  • • Pituitary carcinoma

      ea0032s17.1
    • Medical treatment of adrenocortical cancer

      ea0032s17.2
    • Abstract unavailable

      ea0032s17.3
  • PCOS
  • • Environmental impact on the PCOS phenotype

      ea0032s18.1
    • PCOS in adolescence: towards a therapy targeting adipose tissue

      ea0032s18.2
    • The diagnosis of PCOS in adults: new biomarkers

      ea0032s18.3
  • Recent advances in the molecular study of endocrine tumours: microRNAs and more
  • • TGF-[beta] signaling and the microRNA machinery

      ea0032s19.1
    • MicroRNAs in pituitary tumours

      ea0032s19.2
    • MicroRNAs and gene expression patterns in adrenal tumours

      ea0032s19.3
  • New mechanisms of energy balance
  • • Abstract unavailable

      ea0032s20.1
    • Programming of host metabolism by the gut microbiota

      ea0032s20.2
    • Abstract unavailable

      ea0032s20.3
  • Multi-centre pituitary studies
  • • New classification of pituitary tumours based on the hypopronos database

      ea0032s21.1
    • Lessons from the Liege Acromegaly Survey (LAS)

      ea0032s21.2
    • Lessons from the European Cushing's registry (ERCUSYN)

      ea0032s21.3
  • Improving diagnosis of primary aldosteronism
  • • Genetics of primary aldosteronism

      ea0032s22.1
    • Abstract unavailable

      ea0032s22.2
    • Adrenal vein sampling

      ea0032s22.3
  • Endocrine disruptors (Supported by Endocrine Connections)
  • • Abstract unavailable

      ea0032s23.1
    • Male reproductive health and endocrine disrupters

      ea0032s23.2
    • Are structural analogs to bisphenol A a safe alternative?

      ea0032s23.3
  • Redefining our understanding of the causes of obesity
  • • Abstract unavailable

      ea0032s24.1
    • Social stress, obesity and type 2 diabetes

      ea0032s24.2
    • Ambient temperature and other environmental factors in obesity

      ea0032s24.3
  • Rare metabolic bone disease
  • • Paget's disease of bone: how to treat and monitor patients

      ea0032s25.1
    • Osteogenesis imperfecta

      ea0032s25.2
    • Abstract unavailable

      ea0032s25.3
  • Novel technologies and inspiring ideas: From basic endocrine research to clinical practice (European Young Endocrine Scientists (EYES) Symposium)
  • • Making a functional thyroid in a dish

      ea0032s26.1
    • Dissecting androgen action: new clues from conditional knockout mice

      ea0032s26.2
    • Abstract unavailable

      ea0032s26.3
  • Steroids in obesity and metabolism
  • • 11[beta]-Hydroxystreroid dehydrogenase activity and obesity

      ea0032s27.1
    • Metabolic control through glucocorticoid hormones

      ea0032s27.2
    • Glucocorticoid-mediated fetal programming in humans

      ea0032s27.3
  • Autoimmune endocrine disease - Old and new players
  • • Autoimmune thyroid disease

      ea0032s28.1
    • Autoimmune Addison's disease: new players in diagnosis and treatment

      ea0032s28.2
    • Hypophysitis

      ea0032s28.3
  • Management of thyroid nodules
  • • Molecular analysis of FNAB material

      ea0032s29.1
    • Diagnostic pitfalls in fine needle aspiration of thyroid nodules

      ea0032s29.2
    • Follow-up of benign nodules

      ea0032s29.3
  • Energy Status and pituitary function
  • • Energy status and puberty: novel neuroendocrine regulatory mechanisms

      ea0032s30.1
    • Energy status and glucocorticoid excess

      ea0032s30.2
    • Energy status and GH/IGF1 axis

      ea0032s30.3
  • Clinical impact of rare mutations in endocrinology
  • • Does a new mutation always predict a new disease? Lessons from p27 mutations

      ea0032s31.1
    • Old and new MEN1 mutations

      ea0032s31.2
    • Genetic diagnosis of hereditary neuroendocrine syndrome in asyntomatic patients: clinical and prognostic implications

      ea0032s31.3
  • Is diabetes a lipid disease?
  • • Abstract unavailable

      ea0032s32.1
    • Fatty liver disease

      ea0032s32.2
    • Adipose tissue lipolysis and insulin sensitivity

      ea0032s32.3
• Meet the Expert Sessions
• • (1)
  • • What systems biology can do for endocrine research?

      ea0032mte1
    • Abstract unavailable

      ea0032mte2
    • Insulin therapy

      ea0032mte3
    • Abstract unavailable

      ea0032mte4
    • Current guidelines for the classification of net

      ea0032mte5
    • New immunotherapy approaches for Graves' orbitopathy

      ea0032mte6
    • Abstract unavailable

      ea0032mte7
    • Abstract unavailable

      ea0032mte8
    • Abstract unavailable

      ea0032mte9
    • Abstract unavailable

      ea0032mte10
    • Abstract unavailable

      ea0032mte11
    • Abstract unavailable

      ea0032mte12
    • Hypogonadotropic hypogonadism

      ea0032mte13
    • Abstract unavailable

      ea0032mte14
    • Abstract unavailable

      ea0032mte15
    • Diabetic foot disease for endocrinologists

      ea0032mte16
• JOE/JME Prize Presentation <emphasis role="italic">Sponsored by</emphasis><ulink url="http://jme.endocrinology-journals.org"><emphasis role="italic">Journal of Molecular Endocrinology</emphasis></ulink>
• • Enhancing radioiodine uptake in thyroid cancer
  • • Enhancing radioiodine uptake in thyroid cancer

      ea0032jp1
• Endocrine Nursing Symposium
• • (1)
  • • Pre- and post-operative care of the patient undergoing pituitary surgery

      ea0032en1.1
    • Pituitary dynamic testing

      ea0032en1.2
    • Abstract unavailable

      ea0032en1.3
    • GH replacement in adults

      ea0032en1.4
    • Abstract unavailable

      ea0032en1.5
    • The role of the endocrine nurse in the care and treatment of children with congenital adrenal hyperplasia and in their transition to the adult service

      ea0032en2.1
    • Management of CAH in adults

      ea0032en2.2
    • A patient's perspective of CAH: the importance of care

      ea0032en2.3
    • Abstract unavailable

      ea0032en2.4
    • Abstract unavailable

      ea0032en2.5
    • The endocrinology nursing in Denmark

      ea0032en3.1
    • Incorporating research in to the role of the endocrine nurse: an example from my practice

      ea0032en3.2
    • Competency framework for the endocrine clinical nurse specialist

      ea0032en3.3
    • Abstract unavailable

      ea0032en3.4
    • Abstract unavailable

      ea0032en3.5
• Oral Communications
• • Pituitary & Molecular Endocrinology
  • • The consequences of changing endogenous GH/IGF1 levels on carcinogen-induced mammary gland tumorigenesis are dependent on metabolic status in mice

      ea0032oc1.1
    • Involvement of the constitutive activity of the GHS-R1a (ghrelin G-protein coupled receptor) in the tumorigenesis of somatotroph adenomas

      ea0032oc1.2
    • Heterodimerisation of FSH and LH receptors positively modulates the LH-induced signalling profile

      ea0032oc1.3
    • BKM120, a pure PI3K inhibitor: a promising treatment for aggressive pituitary tumors or pituitary carcinomas

      ea0032oc1.4
    • Differential effect of octreotide treatment on expression of sstr2a, 3 and 5 in somatotroph adenomas

      ea0032oc1.5
    • Management of euvolemic hyponatremia attributed to SIADH in the hospital: interim results from a prospective, observational, multi-center, global registry

      ea0032oc1.6
  • Bone & Calcium
  • • Bone mass accrual following supplementation of vitamin D alone versus vitamin D+ calcium in underprivileged Indian premenarcheal girls

      ea0032oc2.1
    • Influence of vitamin D and calcium on reproductive hormones: a study in a VDR-ablated male mouse model and 300 healthy men

      ea0032oc2.2
    • Screening for GNAS genetic and epigenetic alterations in progressive osseous heteroplasia: first Italian series

      ea0032oc2.3
    • Natural course of changes in bone mineral density after orthotopic liver transplantation: up to 5 years follow-up in a single centre

      ea0032oc2.4
    • Genetic analysis of CDKN1B gene in familial primary hyperparathyroidism

      ea0032oc2.5
    • Hypomineralized teeth as biomarkers of exposure to endocrine disruptors

      ea0032oc2.6
  • Thyroid
  • • Targeting of PATZ1 by miR-29b is a downstream effect of oncogenic Ras signalling in thyroid cells

      ea0032oc3.1
    • Mitochondrial mass and function is regulated by PI3K signaling in thyroid cancer cells

      ea0032oc3.2
    • SP600125, a new p53 selective anticancer drug: effects on poorly differentiated thyroid cancers

      ea0032oc3.3
    • DNA methylation signatures identify biologically distinct thyroid cancer subtypes

      ea0032oc3.4
    • Role of the calcium-calmodulin dependent kinase 2 in medullary thyroid carcinoma

      ea0032oc3.5
    • Subclinical hyperthyroidism and risk of cardiovascular and all-cause mortality

      ea0032oc3.6
  • Adrenal
  • • Pre-clinical model detects castrate-resistant cancer repopulating cells in localised prostate tumours

      ea0032oc4.1
    • Single nucleotide polymorphism array profiling of adrenocortical tumors: evidence for an adenoma carcinoma sequence?

      ea0032oc4.2
    • Prognostic factors of advanced unresectable by stage III and IV ENS@T adrenocortical carcinomas (ACC)

      ea0032oc4.3
    • Neuronal dysfunction in the hippocampi of cured Cushing's syndrome patients, detected by 1H-MR-spectroscopy

      ea0032oc4.4
    • Influence of somatic mutations on the lateralization index of adrenal vein sampling in aldosterone producing adenomas

      ea0032oc4.5
    • 9-cis retinoic acid, a novel treatment option for adrenocortical cancer? in vitro and in vivo studies

      ea0032oc4.6
  • Reproduction
  • • BMP15-dependent gene-expression profiling in human granulosa cells

      ea0032oc5.1
    • The (TAAAA)n polymorphism in the SHBG gene is related to prenatal androgenization of female fetus: possible implications of the developmental origin of metabolic disorders

      ea0032oc5.2
    • Age-related hormonal and metabolic alterations in women with polycystic ovary syndrome (PCOS)

      ea0032oc5.3
    • Influence of variants in the FSHB and FSHR gene on reproductive parameters in males and females

      ea0032oc5.4
    • FSHB -211 and FSHR 2039 polymorphisms are associated with serum levels of FSH, AMH and age of pubertal onset in 78 healthy girls: a longitudinal cohort study

      ea0032oc5.5
    • INSL3 in 268 male patients with congenital hypogonadotropic hypogonadism (CHH): effects of different modalities of hormonal treatment

      ea0032oc5.6
  • Diabetes & Obesity
  • • Type 2 diabetes risk alleles frequencies in the Portuguese population

      ea0032oc6.1
    • Dissociation between high fat diet-induced obesity (DIO) and insulin resistance: lessons from AHNAK knockout mice

      ea0032oc6.2
    • Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men

      ea0032oc6.3
    • Reduction of fat mass with the mTOR inhibitor, sirolimus, in humans: from transplantation to lipodystrophies

      ea0032oc6.4
    • The role of costimulatory molecules B7.1 and B7.2 in obesity-related adipose tissue inflammation and liver steatosis

      ea0032oc6.5
    • Serum- and glucocorticoid-regulated kinase 1 in obesity-related adipose tissue and peripheral inflammation

      ea0032oc6.6
• Nurse Posters
• • (1)
  • • Pegvisomant home care program is likely to improve treatment compliance leading to rapid IGF1 control

      ea0032n1
    • Psychiatric morbidity in pediatric patients after surgical remission of Cushing's disease: case presentations

      ea0032n2
    • Living in the shadow and light: Iranian youths' response to diabetes-related stigma

      ea0032n3
    • Nurse led telephone clinic: antenatal hypothyroidism

      ea0032n4
    • Assessing treatment satisfaction, knowledge and adherence of patients attending a pituitary Nurse-led Clinic

      ea0032n5
• Poster Presentations
• • Adrenal cortex
  • • Chronocort[reg], a multiparticulate modified release hydrocortisone formulation, shows dose linearity and twice daily dosing provides physiological cortisol exposure

      ea0032p1
    • Impaired quality of life in CAH adults is associated with adiposity and insulin resistance

      ea0032p2
    • Correlation between cell cycle, steroidogenesis and PKA RIA and RIIB subunits in adrenocortical tumors cells

      ea0032p3
    • Long-term follow-up in adrenal incidentalomas: an Italian Multicentre Study

      ea0032p4
    • The gene expression profile of cortisol secretion in adrenocortical adenomas

      ea0032p5
    • Activation of EGFR promotes ACC cell proliferation by inducing VEGF autocrine secretion

      ea0032p6
    • Human leukocyte antigen (DQ2/DQ8) and 21-hydroxylase antibodies determine the thyroid peroxidase antibody status of patients in autoimmune Addison's disease

      ea0032p7
    • Plasma metanephrine for assessing the selectivity of adrenal venous sampling

      ea0032p8
    • Insulin sensitivity in patients with Addison's disease: a randomised cross-over trial comparing conventional glucocorticoid replacement therapy with continuous subcutaneous hydrocortisone infusion therapy.

      ea0032p9
    • First phase insulin secretion is impaired by aldosterone excess in primary aldosteronism

      ea0032p10
    • Molecular screening for personalized treatment approach in advanced adrenocortical cancer

      ea0032p11
    • Abstract unavailable

      ea0032p12
    • Detection of circulating tumor cells in adrenocortical carcinoma: a monocentric preliminary study

      ea0032p13
    • New diagnostic methods for primary aldosteronism with specific antibodies

      ea0032p14
    • [em]In vivo [em] and [em] in vitro[/em] evidence supporting SSTR/mTOR pathway targeting in adrenocortical cancer

      ea0032p15
    • Mortality in long-term follow-up patients with progressively increased patterns of subclinical cortisol hypersecretion

      ea0032p16
    • Role of adrenal vein sampling in primary aldosteronism: impact of different diagnostic criteria on subtype diagnosis

      ea0032p17
    • The diagnosis of nonclassical congenital adrenal hyperplasia due to 21 hydroxylase deficiency in woman can be established by genetic testing or urine steroid profile analysis but not by ACTH stimulation test

      ea0032p18
    • Genetic analysis does not confirm NCCAH in almost half of the women who had received this diagnosis: preliminary results of an audit

      ea0032p19
    • Investigation of [beta]-catenin, N-cadherin, and E-cadherin expression in adrenocortical tumors

      ea0032p20
    • Bilateral inferior petrosal sinus sampling in cushing's syndrome: comparison between an old and a new technique in naples experience

      ea0032p21
    • 21-hydroxylase and interferon omega autoantibodies in Turner syndrome

      ea0032p22
    • Immunohistochemical markers of adrenal cortical tumors

      ea0032p23
    • Management of Addison's disease patients using dual release hydrocortisone during periods of intercurrent illness

      ea0032p24
    • Abstract unavailable

      ea0032p25
    • Longitudinal assessment of adrenocortical responses to low-dose ACTH in critically ill septic patients

      ea0032p26
    • Increasing prevalence of Addison's disease in Germany: health insurance data 2007-2011

      ea0032p27
    • The role of late-night salivary cortisol measurement in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentalomas

      ea0032p28
    • Aldosterone measurement: performances of a new fully automated chemilunescence-based immunoassay

      ea0032p29
    • Patients with Addison's disease have increased frequency of the metabolic syndrome: a case-control study

      ea0032p30
    • Reliability of serum versus salivary cortisol in ACTH test

      ea0032p31
    • Diagnostic performance of first line biochemical tests to differentiate ACTH-ectopic syndrome among ACTH dependent Cushing's syndrome

      ea0032p32
    • Salivary cortisol is a useful tool to assess the immediate response to pasireotide in patients with Cushing's disease

      ea0032p33
    • Male hypogonadism in Addison's disease - an under-recognized problem

      ea0032p34
    • A national survey on the prevalence and treatment outcome of active Cushing's disease in Belgium

      ea0032p35
    • More than two successive measurements of late-night salivary cortisol are needed to accurately diagnose early-stage post-surgical recurrence of Cushing's disease

      ea0032p36
    • Adrenal venous sampling is mandatory and CT scan is unreliable for diagnosing unilateral primary hyperaldosteronism

      ea0032p37
    • Endosonography-guided fine-needle aspiration biopsy in differential diagnosis of adrenal gland tumours - pilot study

      ea0032p38
    • The Urinary Aldosterone in the Diagnosis of Primary Aldosteronism

      ea0032p39
    • Autoimmune polyglandular syndrome on a cohort of patients with primary adrenocortical insufficiency

      ea0032p40
    • Non-classic adrenal hyperplasia (NCAH) in patients with bilateral adrenal incidentally discovered tumors

      ea0032p41
    • Effect of glucocorticoids treatment on anthropometric parameters and sexual maturation rating in salt wasting and simple virilizing forms of congenital adrenal hyperplasia in Pakistani boys

      ea0032p42
    • Overt and ubclinical hypercortisolism in patients with diabetes mellitus and obesity

      ea0032p43
    • Association of a variant of V281L of 21-hydroxylase gene CYP21A2 with simple virilizing and salt wasting types of CAH in Pakistani population

      ea0032p44
    • Long-term efficacy of pasireotide in a patient with Cushing's disease and diabetes: results in the short term are not always predictive of long-term response

      ea0032p45
    • Autonomous aldosterone secretion as a significant cause of arterial hypertension: the effectiveness of targeted therapy

      ea0032p46
    • Cushing'S syndome: source of ectopic secretion of acth found after 20 years of follow-up

      ea0032p47
    • Glucose tolerance in Cushing's disease

      ea0032p48
    • European Adrenal Insufficiency Registry: a comparative observational study of glucocorticoid replacement therapy

      ea0032p49
    • Oncocytic adrenal carcinoma with production of testosterone and cortisol: case report

      ea0032p50
    • Prevalence of primary aldosteronism among hypertensive population in Trabzon City, Turkey

      ea0032p51
    • Adrenal metastases: aetiolgies and outcome

      ea0032p52
    • Adrenal inclusion in testicular: about six cases

      ea0032p53
    • Hyperaldosteronism in patients with hyperparathyroidism: three cases

      ea0032p54
    • Analyses of data of the patients with Cushing's disease with use of Moscow Region's database

      ea0032p55
    • Evaluation of monitoring protocol for adrenal incidentalomas in our area

      ea0032p56
    • Impact of antihypertensive drugs, sodium intake and potassium plasma concentrations on plasma aldosterone and plasma renin aktivity

      ea0032p57
    • A case of Addison's disease caused by systemic disseminated tuberculosis: mimicking lymphoma on F-18 FDG PET-CT

      ea0032p58
    • Cardiovascular risk in Cushing's syndrome

      ea0032p59
    • Management of adrenal carcinoma in a tertiary center of Endocrinology in Romania

      ea0032p60
    • Severe hyperglycemia due to cortisol producing adrenal carcinoma

      ea0032p61
    • Metastatic adrenocortical carcinoma presenting with concomitant secretion of glucocorticoid, mineralocorticoid, androgen, and catecholamines: a case report

      ea0032p62
    • Adrenal lymphoma: about two cases

      ea0032p63
    • Hypercortisolism endogenous and pregnancy: a report of three cases

      ea0032p64
  • Adrenal Medulla
  • • Stud phenotypic study of paraganglioma extra surrenlien: about height cases

      ea0032p65
    • Plasma free metanephrine and normetanephrine in chronic kidney disease patients

      ea0032p66
    • Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation

      ea0032p67
    • Adrenal ganglioneuroma in a patient with a non-Hodgkin lymphoma

      ea0032p68
    • Evaluation of patients with pheochromocytoma for 10 yearly period

      ea0032p69
  • Bone and Osteoporosis
  • • Bone loss in inflammation-mediated osteoporosis: a role for the P2[times]7 receptor?

      ea0032p70
    • Abstract unavailable

      ea0032p71
    • Circadian rhythm of circulating sclerostin in healthy young men

      ea0032p72
    • Cross-correlation of circulating sclerostin over 24 h to PTH, phosphate and bone markers in healthy young men

      ea0032p73
    • Bone quality, as measured by trabecular bone score (TBS), in patients with primary hyperparathyroidism

      ea0032p74
    • Calcium homeostasis in women with non-metastatic breast cancer with osteoporosis after a single-dose of denosumab: a pilot study

      ea0032p75
    • Long-term prospective evaluation of the effects of estroprogestagen therapy on the bone mineral density of girls with Turner syndrome carrying various PvuII AND XbaI polymorphisms of ER-[alpha]

      ea0032p76
    • Cathepsin K secretion in human primary osteoblastic cell cultures and its influence by different glucose concentrations

      ea0032p77
    • Effects of Denosumab treatment on insulin resistance in postmenopausal women with osteoporosis

      ea0032p78
    • Impact of the FRAX[reg] tool and the NOGG guidelines on the indication of bone mineral density in Spanish postmenopausal women

      ea0032p79
    • Increased IL17A serum levels associated with low estrogen levels can play a role in postmenopausal osteoporosis

      ea0032p80
    • Effects of the tamoxifen on calcitonin producing thyroid C cells and bone in rat model of male osteoporosis

      ea0032p81
    • The value of PRP/PRF in the treatment of bisphosphonates-induced maxillary osteonecrosis: preliminary study

      ea0032p82
    • Bone mineral density in patients with hypersomatotropism

      ea0032p83
    • Effects of treatment for acromegaly on bone mineral density: is pegvisomant protective on lumbar BMD?

      ea0032p84
    • HLA class I, Cw*01 and Cw*15 alleles can play a preventing role in serum IL17 elevation associated with postmenopausal osteoporosis in Hungary

      ea0032p85
    • Bone health in type 1 diabetes patients with celiac disease

      ea0032p86
    • Oxidative stress in middle age males with osteoporosis: correlation of hormonal pattern and plasma total antioxidant capacity

      ea0032p87
    • Lean body mass and leptin, but not fat mass are independent predictors of bone mass in postmenopausal women

      ea0032p88
    • Association of the (TTTA)n repeat polymorphism of CYP19 gene with bone mineral density in Greek peri- and postmenopausal women

      ea0032p89
    • Vitamin D receptor polymorphisms and bone mass indices in post menarcheal indian adolescent girls

      ea0032p90
    • Bone health in children with GH deficiency

      ea0032p91
    • The effect of monthly Ibandronate on bone mineral density and bone turnover markers in patients with hemophilia A or B and increased risk for fracture

      ea0032p92
    • Age overlooked as a risk factors for osteoporosis

      ea0032p93
    • Trabecular bone score and bone mineral density in Ukrainian normal women depending on duration of postmenopausal period

      ea0032p94
    • Bone metabolism with special emphasis to osteoprotegerin and vitamin D3 concentrations in premenopausal women with thyroid dysfunction

      ea0032p95
    • Efficacy and safety of monthly oral minodronate for the treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients

      ea0032p96
    • Change in bone mass in patients with established hyperthyroidism

      ea0032p97
    • The follow-up in patients evaluated based on quantitative ultrasound: a prospective study

      ea0032p98
    • Prospective study of bone mineral density in girls treated with estroprogestagens for functional hypothalamic amenorrhea during late puberty in relation to the polymorphism of VDR (BsmI), ER (PvuII; Xba I), and COLIA1 genes

      ea0032p99
    • Vertebral fracture prevalence in postmenopausal women in relation to bone mineral density (BMD)

      ea0032p100
    • Vertebral fractures in women with postmenopausal osteoporosis with or without prior fragile fracture

      ea0032p101
    • Effect of long-term valproate therapy on bone health parameters

      ea0032p102
    • Efficacy and safety of the anabolic therapies in severe osteoporosis: experience of a team of endocrinologists and spine surgeons

      ea0032p103
    • Vitamin D receptor, BsmI, FokI, ApaI, TaqI and estrogen receptor alpha, PvuII and XbaI, gene polymorphisms in women with osteoporosis

      ea0032p104
    • Possible benefits of PTH 1-84 therapy in pregnancy and lactation osteoporosis (PLO)

      ea0032p105
    • Influence of some traditional risk factors for osteoporosis on bone metabolism during substitution therapy of primary hypothyroidism

      ea0032p106
    • Resolution of anaemia after curative parathyroidectomy in a patient with primary hyperparathyroidism

      ea0032p107
    • A case of 23 years old woman with primary hyperparathyroidism presenting with pathological fracture and brown tumors detected by scintigraphy

      ea0032p108
    • A patient osteogenesis imperfecta with osteoporosis

      ea0032p109
    • Fear of illness and quality of life in Greek postmenopausal women with osteoporosis

      ea0032p110
  • Calcium and Vitamin D metabolism
  • • The relationship between low maternal serum 25-hydroxyvitamin D level and gestational diabetes mellitus according to the severity of 25-hydroxyvitamin D deficiency

      ea0032p111
    • Effects of vitamin D fortified bread on muscle strength

      ea0032p112
    • Evaluation of two routinely used 25OHD assays and serum variables in patients on dialyses

      ea0032p113
    • Vitamin D supply in healthy women with different reproductive stages: is there any relationship with DBP levels?

      ea0032p114
    • Cinacalcet in patients with primary hyperparathyroidism (PHPT): comparison between sporadic and MEN1 PHPT

      ea0032p115
    • Efficacy of vitamin D on COPD exacerbation: a double blind randomized placebo-controlled clinical trial

      ea0032p116
    • Lower CD4 lymphocyte counts in HIV/HCV co-infected patients with liver fibrosis on long term HAART and low vitamin D level

      ea0032p117
    • Replenishment of reduced vitamin D levels: how much vitamin D is necessary?

      ea0032p118
    • Changes in anxiety and depression symptoms in patients with chronic fatigue syndrome treated with vitamin D

      ea0032p119
    • The effects of vitamin D therapy on thyroid functions, thyroid autoantibodies, TNF-[alpha];, IL6 and IL1b in patients with autoimmune thyroiditis

      ea0032p120
    • Genetic analysis of AIP genes in familial primary hyperparathyroidism

      ea0032p121
    • A986S or the R990G polymorphism in CASR does not explain hypercalciuria and low normal serum calcium

      ea0032p122
    • Early measure of postoperative iPTH and corrected calcium as predictors of future hypoparathyroidism: which, when and why?

      ea0032p123
    • Serum sclerostin and Dkk1 in patients with parathyroid disorders

      ea0032p124
    • An observational study reveals that neonatal vitamin D is primarily determined by maternal contributions: implications of a new assay on the roles of vitamin D forms

      ea0032p125
    • Vitamin D and sarcopenia in HIV-infected patients

      ea0032p126
    • Lithium-associated hyperparathyroidism: a case report

      ea0032p127
    • Late-onset hypoparathyroidism 15 years after thyroidectomy

      ea0032p128
    • Does recognition of vitamin D deficiency affect the indication for surgical treatment in asymptomatic primary hyperparathyroidism?

      ea0032p129
    • Fahr's disease with dystonia: a case report

      ea0032p130
    • Predictive factors of postoperative hypoparathyroidism after total thyroidectomy

      ea0032p131
    • Normocalcemic primary hyperparathyroidism: an Italian epidemiologic study

      ea0032p132
    • Plasma lipid levels in relation to the status of vitamin D sufficiency

      ea0032p133
    • Primary hyperparathyroidism and vitamin D deficiency. therapeutic implications

      ea0032p134
    • Prevalence and correlates of vitamin D deficiency in Turkish adults

      ea0032p135
    • Vitamin D deficiency in urban adult population of south-eastern Poland

      ea0032p136
    • The effects of lactose intolerance and lactose intolerance associated diseases on serum vitamin D levels, bone metabolism markers, bone mineral density and bone fractures

      ea0032p137
    • Normocalcemic hyperparathyroidism

      ea0032p138
    • Familiar hypocalciuric hypercalcemia a rare cause of hypercalcemia

      ea0032p139
    • Vitamin D deficiency in lithuanian school graduates females

      ea0032p140
    • Does vitamin D status predict handgrip strength in young adult women?

      ea0032p141
    • Influence of preoperative characteristics in the result of Tc99m-sestaMIBI scan in patients with primary hyperparathyroidism

      ea0032p142
    • Cystic parathyroid adenomas: ultrasonography features

      ea0032p143
    • Primary hypoparathyroidism and autoimmune endocrine disorders

      ea0032p144
    • Experience in the treatment of primary hyperparathyroidism with cinacalcet: data after 12 months of treatment

      ea0032p145
    • Primary hyperparathyroidism in people under 30

      ea0032p146
    • An extensive precipitation of calcium in subcutaneous tissue in patient with juvenile dermatomyositis

      ea0032p147
    • Measurement of 25-hydroxyvitamin D: evaluation of the new DIAsource ELISA assay

      ea0032p148
    • Persistent primary hyperparathyreoidism

      ea0032p149
    • Prevalence of multiple endocrine neoplasia type 1 syndrome in primary hyperparathyroidism

      ea0032p150
    • Does the severity of vitamin D deficiency affect the prevelance of gastrointestinal polyps?

      ea0032p151
    • Vitamin D deficit and metabolic syndrome

      ea0032p152
    • Vitamin D deficiency predicts incidence of obesity

      ea0032p153
    • Vitamin D deficiency in morbid obesity before and after bariatric surgery

      ea0032p154
    • The association of low serum 25-hydroxyvitamin D and serum osteocalcin levels with the metabolic syndrome in females with polycystic ovary syndrome in Al-Baha region, Saudia Arabia: a case-control study

      ea0032p155
    • MSIA--SRM assay for parathyroid hormone and vitamin D binding protein: correlation with clinical immunoassay methods and application to clinical samples

      ea0032p156
    • Vitamin D deficiency, secondary hyperparathyroidism and it's influence on bone mineral density

      ea0032p157
    • Comparative study of bone metabolic parameters and vitamin D levels of fertile aged women, suffering from different bone metabolism altering diseases

      ea0032p158
    • Structure and frequency of clinical manifestations of primary hyperparathyroidism

      ea0032p159
    • A case report: hypoparathyroidism, nephrocalcinosis, and replacement therapy

      ea0032p160
    • Abstract unavailable

      ea0032p161
    • The prognostic value of peripheral neuropathy for the mortality and its relation to secondary hyperparathyreoidism: a 10-month follow up of 97 patients with end-stage renal disease

      ea0032p162
    • Postsurgical hypoparathyroidism with 'normal' PTH

      ea0032p163
    • Evaluation of concentration 25OH vitamin D 3 selected patient population: preliminary report

      ea0032p164
    • Evaluation of concentration 25OH vitamin D 3 in the population over 65 years old: preliminary report

      ea0032p165
    • Cardio-metabolic risk factors in subjects with Vit D deficiency

      ea0032p166
    • Hyperparthyroidism: are male forms more or less aggressive?

      ea0032p167
    • A clinical case of complicated hyperparathyroidismwith diagnosis delay due to vitamin D deficiency

      ea0032p168
    • Impact of vitamin deficiency and oF GH-IGF1 on cardiovascular risk in hypopituitaric patients

      ea0032p169
    • Primary hyperparathyroidism in patients with urolithiasis: prevalence and predictors

      ea0032p170
    • Could PHPT be diagnosed at early stages even more frequently?

      ea0032p171
    • Relation between carotid intima media thickness and vitamin D in hypertension

      ea0032p171.1
  • Cardiovascular Endocrinology & Lipid Metabolism
  • • Lipid levels in acromegaly

      ea0032p172
    • Testosterone stimulates cholesterol metabolism and efflux from human macrophages via liver X receptor

      ea0032p173
    • Testosterone differentially regulates liver X receptor expression and targets of lipid and glucose metabolism in liver, muscle and adipose tissue of the testicular feminised mouse

      ea0032p174
    • Oxytocin, a new regulator of cardiomyocyte hypertrophy

      ea0032p175
    • Long QT interval in Turner syndrome: a high prevalence of LQTS gene mutations

      ea0032p176
    • Osteoprotegerin and RANKL levels in instable coronary artery disease

      ea0032p177
    • Intestinal cholesterol-transport gene expression is associated with abnormalities in post-prandial endothelial function and carotid intima-media thickness independent of insulin resistance

      ea0032p178
    • Mediterranean diet modulates the effect of rs1761667 in the CD36 gene on FFA concentration and BMI in a high cardiovascular risk population

      ea0032p179
    • The effect of aerobic exercise on ectopic lipids intramyocellular, intrahepatocellular, and intracardiomyocellular lipids in physically active, healthy individuals

      ea0032p180
    • Can hypothyroidism manifest as ischemic heart disease in elderly patients with the absence of significant coronary atherosclerosis?

      ea0032p181
    • Short-term changes in serum sex steroid levels and cardiac function in healthy young men

      ea0032p182
    • Mendelian randomization suggests non-causal associations of testosterone with cardiometabolic risk factors and mortality

      ea0032p183
    • Adults with GH deficiency have subclinical longitudinal left ventricular dysfunction, without significant vascular function impairment, suggesting intrinsic myocardial disease

      ea0032p184
    • Mechanism of oxytocin-mediated cardiomyocyte protection

      ea0032p185
    • The effect of testosterone replacement on endothelial dysfunction, inflammation and insulin resistance in male hypogonadotrophic hypogonadism

      ea0032p186
    • TSH and arterial stiffness in healthy postmenopausal women

      ea0032p187
    • A potential predict value of circulating osteoprotegerin in diabetic patients with asymptomatic coronary artery disease

      ea0032p188
    • Metabolic profile of transsexual persons on cross-sex hormonal therapy in a multi-center prospective intervention study

      ea0032p189
    • Changes in lipid profile and markers of metabolic syndrome after 3 years of testosterone-therapy in female-to-male transsexuals

      ea0032p190
    • Pentraxin-3 as a more sensitive marker of coronary artery disease severity than C-reactive protein

      ea0032p191
    • Effect of cross-sex hormone treatment on lipid profile in transsexual individuals: experience in a specialized unit in Catalonia

      ea0032p192
    • HDL cholesterol subfractions and the effect of testosterone replacement in hypogonadism

      ea0032p193
    • The activity of inflammation and the blood redox status in patients with coronary heart disease and type 2 diabetes mellitus

      ea0032p194
    • Utility of N-terminal pro-brain natriuretic peptide in the evaluation of patients with high clinical probability of non-ST segment elevation acute coronary syndrome

      ea0032p195
    • Perturbed sympatho-vagal balance in Turner syndrome: relation to phenotype and aortic dilation

      ea0032p196
    • Impact of subclinical thyroid dysfunction on mortality among patients presenting with cardiovascular events

      ea0032p197
    • Abstract unavailable

      ea0032p198
    • Lipid levels in patients with rheumatoid arthritis and the effect of rituximab

      ea0032p199
    • Linear growth and IGF1 concentrations in children cyanotic and acyanotic congenital heart disease before vs after intervention

      ea0032p200
    • Changes of expression of regulators of calcification in different stages of atherosclerosis in vasculature and bone

      ea0032p201
    • Dyslipidemia associated with m-TOR inhibitors treatment

      ea0032p202
    • Rising prevalence of fatty liver in India and its correlates

      ea0032p203
    • CNR1 polymorphisms and metabolic disorders in woman with PCOS-preliminary report

      ea0032p204
    • Oleic vs linoleic effects on hepatic sex hormone-binding globulin production

      ea0032p205
    • Post prandial responses in insulin, free fatty acid and endothelial function following to Malaysian vs Mediterranean meals among healthy subjects

      ea0032p206
    • Subclinical atherosclerosis and cardiovascular risk in healthy, young menopausal women

      ea0032p207
    • Comparative effects of atorvastatin and rosuvastatin on vitamin D levels, glucose metabolism and systematic inflammation in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study

      ea0032p208
    • Clinical experience with exenatide and liraglutide in the internal medicine service two of hospitals in Valencia

      ea0032p209
    • Effect of one session resistance exercise on C-reactive protein and cardio metabolic risk factors in trained and untrained healthy students

      ea0032p210
    • Combination therapy in diabetic patients with insulin glargine and exenatide in the internal medicine service two of hospitals in Valencia

      ea0032p211
    • Metabolic disorders in a group of Algerian hypersomatotropic subjects

      ea0032p212
  • Clinical case reports – Pituitary/Adrenal
  • • Case report: chronic adrenergic stimulation induces brown adipose tissue differentiation in visceral adipose tissue

      ea0032p213
    • An unusual case of Cowden-like syndrome, neck paraganglioma and pituitary adenoma

      ea0032p214
    • Follicle-stimulating hormone-secreting pituitary macroadenoma: a rare cause of abnormal menstrual cycles in a teenage girl

      ea0032p215
    • Long-term treatment with octreotide in a patient with malignant pheochromocytoma: impact on survival and time to tumor progression

      ea0032p216
    • Histologically surprising nasal polyps

      ea0032p217
    • Hypopituitarism and pituitary masses in patients with non-pituitary malignancy

      ea0032p218
    • Wegener granulomatosis as an uncommon cause of panhypopituitarism in childhood

      ea0032p219
    • Adequate timing for adrenalectomy in pheochromocytoma multisystem crisis: can early biochemical diagnosis be the key?

      ea0032p220
    • Complex hypothalamic disorder after childhood histiocytosis X

      ea0032p221
    • Morphologial and functional abnormalities of the hypofyse in patients with diagnose of CFS or fibromyalgia. An example of misdiagnosis by Belgian chronic fatigue centres

      ea0032p222
    • Pineal gland tumor and panhypopituitarism in an adult male

      ea0032p223
    • Antepartum pituitary insufficiency in type 1 diabetes

      ea0032p224
    • Delivery of health child in acromegaly patient with McCune-Albright syndrome treated with lanreotide and pegvisomant during pregnancy

      ea0032p225
    • Intrasellar plasmacytoma: an unusual presentation of multiple myeloma

      ea0032p226
    • Corticomedullary mixed adrenal tumor

      ea0032p227
    • Xanthomatous hypophysitis as a cause of cluster headache: a case report

      ea0032p228
    • Primary adrenal insufficiency in a case of bilateral adrenal hemorrhage secondary to anti-phospholipid syndrome masquerading as chronic abdominal pain

      ea0032p229
    • Very late growth acceleration in a man with hypopituitarism

      ea0032p230
    • Differential diagnosis of aggresive macroprolactinoma, adenoma or atypical adenoma: a case report

      ea0032p231
    • Bilateral third nerve palsy secondary to an apoplexy in a pituitary macroadenoma causing Cushing's disease: a very rare complication of a rare entity

      ea0032p232
    • Good response to temozolamide therapy in a man with a prolactin secreting pituitary carcinoma

      ea0032p233
    • Combined choroidal neovascularization and hypopituitarism in a patient with homozygous mutation in methylenetetrahydrofolate reductase gene

      ea0032p234
    • Acute pulmonary edema as the initial presentation of a pheochromocytoma: case report

      ea0032p235
    • Pleuropericarditis effusion secondary to chronic bromocriptine intake

      ea0032p236
    • Suppurative meningitis as a life threatening primary presentation of macroprolactinomas

      ea0032p237
    • Craniofacial fibrous dysplasia and pituitary gigantism in a 10-year-old boy: clinical case

      ea0032p238
    • Functional and transient effect of sodium excretion in combined pituitary failure with central and peripheric diabetes insipidus

      ea0032p239
    • Management of resistant prolactinoma: case report

      ea0032p240
    • Addisonian crisis: rapid correction of hyponatriemia leads to osmotic myelinolysis

      ea0032p241
    • Pituitary apoplexy after suppression test in a patient with Cushing's disease due to macroadenoma

      ea0032p242
    • Osteoporotic fractures as manifestation of Cushing's disease

      ea0032p243
    • Cerebrospinal meningitis in 30-year-old man as first manifestation of pituitary macroadenoma

      ea0032p244
    • Ectopic acth dependent Cushing syndrome diagnosed with octreotide scan

      ea0032p245
    • Thalassemia minor associated with multiple pituitary hormone deficiency

      ea0032p246
    • Occurrence of De Quervain's thyroiditis after resolution of hypercortisolism following SOM230 treatment for Cushing's disease and surgery for an adrenocortical adenoma: report of two cases

      ea0032p247
    • Nephrogenic systemic fibrosis: potential aetiology of pituitary stalk thickening post- commencement of dialysis: case report

      ea0032p248
    • Extraadrenal paraganglioma: case report

      ea0032p249
    • Newly discovered adrenal tumor and pituitary microadenoma in a patient known with classical congenital adrenal hyperplasia

      ea0032p250
    • Malignant schwannoma in a patient with hypopituitarism, congenital hydrocephalus, atrial septal defect and agenesis of right kidney

      ea0032p251
    • Non-Hodgkin's lymphoma presenting as anterior hypopituitarism

      ea0032p252
    • A case of ACTH producing oat cell carcinoma cause of ectopic Cushing's syndrome and life threatening hypokalaemia

      ea0032p253
    • Recurrent pituitary tumor: the importance of a functional classification at diagnosis

      ea0032p254
    • Congenital trans-sphenoidal meningocele: an uncommon cause of pituitary insufficiency

      ea0032p255
    • Isolated ACTH deficiency with Brugada syndrome: a combination increasing the risk of fatal arrhythmia

      ea0032p256
    • A case of primary adrenal failure diagnosed in postpartum period

      ea0032p257
    • TSH secreting pituitary adenoma: a case report

      ea0032p258
    • Gastrointestinal bleeding associated with Dabigatran in a patient with panhypopituitarism

      ea0032p259
    • Therapeutic dilemmas in a young male patient with macroprolactinoma complicated by hypogonadism

      ea0032p260
    • Baraitser Winter's syndrome and GH deficiency

      ea0032p261
    • Beer potomania masquerading as adrenal insufficiency

      ea0032p262
    • Isolated ACTH deficiency associated with Hashimoto's disease

      ea0032p263
    • Cases with adrenocortical carcinoma

      ea0032p264
    • Differential diagnosis of an incidental pituitary lesion detected with PET-CT in a patient with a known history of metastatic maxillary sinus tumor

      ea0032p265
    • Secondary hypertension and hirsutism as a clinical manifestation of the tumor duplicity: case report

      ea0032p266
    • Treatment dilemmas of Cushing disease: case report

      ea0032p267
    • Adrenocortical carcinoma: a case report

      ea0032p268
    • Fountain of steroid deep within: a case report of an ectopic ACTH-producing tumor

      ea0032p269
  • Clinical case reports - Thyroid / Others
  • • Low TSH plasma levels and high fracture risk in postmenopausal osteoporosis and osteopenia patients

      ea0032p270
    • Malignancy rate of thyroid nodules, which defined as follicular lesion of undetermined significance and atypia of undetermined significance in thyroid cytopathology and relation with ultrasonographic features

      ea0032p271
    • Recurrent pregnancy induced hypercalcaemia resulting in multiple terminations of pregnancy

      ea0032p272
    • Familial Graves' disease: case report

      ea0032p273
    • Paraganglioma, germline nonsense mutation in succinate dehydrogenase B gene (R27X) and response to sunitinib

      ea0032p274
    • Submandibular ectopic thyroid gland

      ea0032p275
    • Barraquer-Simons syndrome

      ea0032p276
    • Dural ectasia accompanying a case of multiple endocrine neoplasia type 2B

      ea0032p277
    • Coexistence of euthyroid ophthalmopathy and isolated ocular myasthenia gravis in a patient with vitiligo: a challenging diagnosis of APS-3C

      ea0032p278
    • Giant cell granuloma as initial presentation of primary hyperparathyroidism: a case report

      ea0032p279
    • Fibrous variant of Hashimoto's thyroiditis: development of neck fibrosis and mediastinal fibrosis

      ea0032p280
    • Differentiated thyroid cancer presenting as chylothorax

      ea0032p281
    • A case of confirmed Smith-Lemli-Opitz syndrome

      ea0032p282
    • A case of generalized resistance to thyroid hormone with chronic thyroiditis

      ea0032p283
    • Autoimmune hypothyroidism converted to hyperthyroidism: is it a common phenomenon?

      ea0032p284
    • Maturity onset diabetes of youth (MODY) in a patient with VATER syndrome

      ea0032p285
    • Plasmapheresis in rapid preparation of a patient with toxic multinodular goiter for surgery

      ea0032p286
    • Postmenopausal hirsutism and hyperandrogenemia due to granulosa cell tumor of the ovary

      ea0032p287
    • Clinical case report: male patient with SRY-positive 46,XX testicular disorder of sex development

      ea0032p288
    • Insulin autoimmune syndrome, IAS (Hirata disease) case report

      ea0032p289
    • Neurogenic hypertension as a case report

      ea0032p290
    • Immobilisation hypercalcaemia in a young man

      ea0032p291
    • Parathyroid carcinoma: an atypical case in a patient submitted to Bariatric surgery

      ea0032p292
    • Autoimmune polyglandular syndrome type IV with twins pregnancy: clinical, diagnostic, evolutive aspects and treatment

      ea0032p293
    • Hypercalcemia in patient five years after the diagnosis of gastrinoma

      ea0032p294
    • Presence of Paget's disease in a patient with endometrium carcinoma

      ea0032p295
    • Parathyroid carcinoma

      ea0032p296
    • Primary hyperparathyroidism associated with atrial septal defect, interatrial septal aneurisym and skeletal anomaly: a case report

      ea0032p297
    • Hypercalciuria in a patient with central diabetes insipidus

      ea0032p298
    • A recurrent case of subacute thyroiditis improved with the onset of pregnancy

      ea0032p299
    • High rate of malignant disorders in patients with primary hyperparathyroidism

      ea0032p300
    • Experience in the use of Tolvaptan in elderly patients with significant hyponatraemia

      ea0032p301
    • Hypercalcemia secondary to concomitant thyrotoxicosis and B cell lymphoma

      ea0032p302
    • Hyperthyroidism-induced heart block: a case series in the Philippine general hospital

      ea0032p303
    • A case with thyroid acropachy as the initial manifestation of thyrotoxicosis

      ea0032p304
    • Postmenopausal Sertoli-Leydig cell tumor in two patients

      ea0032p305
    • Adefovir diproxivil-induced acquired Fanconi's syndrome presenting as hypokalemia

      ea0032p306
    • Prolonged ventilator dependence in myxedema coma: a case report and review of the literature

      ea0032p307
    • Graves' disease associated with severe hypoalbuminemi

      ea0032p308
    • Graves' disease associated with Alopecia areata developed after Hashimoto's thyroiditis

      ea0032p309
    • Challenges in the management of hypogonadotropic hypogonadism

      ea0032p310
    • Abstract removed

      ea0032p311
    • Report of a case of hyperandrogenism in a postmenopausal woman

      ea0032p312
    • Primary octreotide therapy in a patient with pituitary adenoma cosecreting GH and TSH

      ea0032p313
    • Follicular thyroid cancer with functioning lung metastasis

      ea0032p314
    • Wegener's granulomatosis in a patient with vitamin D deficiency

      ea0032p315
    • Mixed medullary-follicular carsinoma of the thyroid: two case reports

      ea0032p316
    • Cyclosporine induced autoimmune thyroid disease: presentation of two cases

      ea0032p317
    • Never too late to discover some extra thyroid tissue

      ea0032p318
    • Everolimus. a new therapeutic target in the metastatic neuroendocrine carcinoma

      ea0032p319
    • Torsade de pointes caused by gluten sensitive enteropathy leading to multiplex endocrine failure: case report

      ea0032p320
    • Atypical parathyroid adenoma presenting with severe hypercalcemia: a case report

      ea0032p321
    • Severe hyponatraemia in patients admitted to acute medical unit

      ea0032p322
    • Androgen abuse complicated by polycythemia in a man with acquired immunodeficiency syndrome (AIDS)

      ea0032p323
    • Abstract unavailable

      ea0032p324
    • A rare presentation of DRESS-associated thyrotoxicosis and myocarditis: case report

      ea0032p325
    • Radiation-induced primary hypothyroidism in patients with head and neck cancer

      ea0032p326
    • A case of type 1 diabetes represented by diabetic ketoacidosis after isotretinoin therapy: is it a result or coincidence?

      ea0032p327
    • Lithium-associated hyperparathyroidism: a case report

      ea0032p328
    • Thyrotoxic periodic paralysis in young Caucasian

      ea0032p329
    • Persimonious indications for thyroidectomy in chronic thyroiditis

      ea0032p330
    • The coexistence of vaginismus with arthritis after pharmacological treatment of hyperthyroidism: is it only a coincidence?

      ea0032p331
  • Developmental Endocrinology
  • • Crystal structure of the complex between an insulin-like peptide (DILP5) and an ILP binding protein (IMP-L2) from Drosophila melanogaster

      ea0032p332
    • Changes in sexual orientation in gender identity disorder: evaluation of their association to sex reassignment surgery and cross-sex hormone treatment

      ea0032p333
    • Somatostatin receptor sst2 transfer in somatolactotroph cell line. Constitutive activity and drug sensitivity

      ea0032p334
    • The distinctive roles of thyroid hormone receptors in the development of zebrafish tissues

      ea0032p335
    • Effects of pharmacological and genetic manipulation of glucocorticoids during early development of the zebrafish embryo

      ea0032p336
    • A study on the relationship between energy reserves and energy expenditure during the time of male puberty

      ea0032p337
    • TurboFlow-LC-MS/MS method for quantification of DHEA, DHEAS, 17[alpha]-hydroxyprogesterone, [delta]-androstenedione and testosterone in children

      ea0032p338
    • The prevalence, incidence and diagnostic delay in 46,XY females; a Danish national cohort study

      ea0032p339
    • Effects of prenatal antiandrogen exposure on HSD3B expression in the fetal porcine gonads

      ea0032p340
    • Characteristics of the HIV positive transgender population of Catalonia

      ea0032p341
    • Optimising strategies for face classification in the detection of acromegaly

      ea0032p342
    • Evaluation of adults with phenyketonuria from pediatric to adult care

      ea0032p343
    • Resistant hypertension: about 30 cases

      ea0032p344
    • High blood pressure in young adults: 84 cases

      ea0032p345
  • Diabetes
  • • Elevation of circulating free fatty acids abolishes down-regulation of skeletal muscle adiponectin receptor 1 (AdipoR1) expression caused by insulin infusion

      ea0032p346
    • Short stature, low-set ears, short 5.finger, undescended testis, bradycardia

      ea0032p347
    • Long-acting insulin analogs exposure and cancer specific mortality in patients with diabetes mellitus

      ea0032p348
    • Expression of adiponectin gene and adiponectin receptors in placental and adipose tissue in women with gestational diabetes mellitus

      ea0032p349
    • Effects of Vaspin on expressions of NF-[k]B and its target genes in endothelial EA.hy926 cells

      ea0032p350
    • Skeletal muscle and adipose tissue glycoprotein 130 expression is associated with insulin resistance in humans

      ea0032p351
    • Increased alanine aminotransferase levels and associated characteristics among newly diagnosed type 2 diabetes patients: results from the DD2 study

      ea0032p352
    • Autoantibodies to the insulin- and IGF1-receptor in human sera

      ea0032p353
    • Physiological role for Angptl4/fiaf in exercise-induced muscle AMPK activation

      ea0032p354
    • Predictive value of HbA1c and glucose fluctuations in hypoglycemia risk in patients with type 1 diabetes

      ea0032p355
    • Risk factors for impaired glucose tolerance and diabetes mellitus after liver transplantation

      ea0032p356
    • Acute exercise leads to increased HbA1c and fructosamine levels in athletes with type 1 diabetes

      ea0032p357
    • Increased alanine aminotransferase levels and associated characteristics among newly diagnosed type 2 diabetes patients: results from the DD2 study

      ea0032p358
    • Reconsidering guidance for postnatal glucose screening in gestational diabetes

      ea0032p359
    • TCF7L2 gene polymorphisms may influence insulin sensitivity and leptin levels independently from BMI and body fat content

      ea0032p360
    • Type 2 diabetes and prostate cancer risk in Korean men with low PSA

      ea0032p361
    • The association between severity of impaired glucose tolerance in gestational diabetes with age, BMI, and ethnicity in the UK

      ea0032p362
    • High prevalence of elevated liver transaminases among 38 727 patients in a diabetes centre in the United Arab Emirates

      ea0032p363
    • Heterozygous deficiency of endoglin decreases insulin and hepatic triglyceride levels during high fat diet

      ea0032p364
    • Prediabetes in human immunodeficiency virus-infected patients: prevalence and clinical significance

      ea0032p365
    • Clinical experience of a monogenic diabetes unit during 2008-2012 in the Department of Endocrinology and Nutrition (Malaga, Spain)

      ea0032p366
    • Progression to impaired glucose metabolism in normal glucose tolerant urban population

      ea0032p367
    • Impact of the insulin pump therapy on quality of life children and adolescents with diabetes mellitus type 1

      ea0032p368
    • Relation of serum chemerin level with markers of atherosclerosis in diabetes and prediabetes

      ea0032p369
    • Serum vaspin levels in women with and without gestational diabetes mellitus during pregnancy and postpartum

      ea0032p370
    • Abstract unavailable

      ea0032p371
    • Association between toll-like receptor 4 polymorphism and type 2 diabetes mellitus

      ea0032p372
    • Altered reactivity of pituitary-adrenal axis to stimulation tests and altered tissue metabolism of cortisol in long-standing type 1 Diabetes

      ea0032p373
    • The effects of gestational diabetes on basal metabolic rate in pregnancy

      ea0032p374
    • Gene expression of TLR2, TLR4, and TLR9 in human PBMCs with diabetes

      ea0032p375
    • Prevalence of achievement of HbA1c, blood pressure, and cholesterol (ABC) Goal in Koreans with diabetes

      ea0032p376
    • Nutritional status assessment in patients with cystic fibrosis

      ea0032p377
    • The expression mechanism of lipocalin-2 by co-stimulation with interleukin 1[beta]; and interferon [gamma]; in RINm5F [beta];-cells

      ea0032p378
    • The effect of CCR2 G190A gene polymorphism on development of diabetic coronary artery disese

      ea0032p379
    • High prevalence of the metabolic syndrome among newly diagnosed type 2 diabetes patients in Denmark

      ea0032p380
    • Trans-operative and post-operative medical complications in patients with diabetes mellitus type 2

      ea0032p381
    • Assessment of pre-pregnancy BMI in patients with gestational diabetes

      ea0032p382
    • Study of the development and validation of the specific [

      ea0032p383
    • Inflammatory markers in diabetic foot and impact of vitamin D deficiency

      ea0032p384
    • Study of the prevalence of subclinical hypothyroidism in type 2 diabetic Egyptian women

      ea0032p385
    • Maternal serum fetuin-A, leptin, and hs-CRP concentrations in gestational diabetes

      ea0032p386
    • The impact of fasting during Ramadan on the glycemic control of patients with type 2 diabetes mellitus

      ea0032p387
    • Identification of plasma biomarkers in human diabetic retinopathy

      ea0032p388
    • Diabetes awareness in the general population of northern Greece

      ea0032p389
    • Insulin resistance among adults with type 1 diabetes mellitus

      ea0032p390
    • Atypical early onset Werner's syndrome

      ea0032p391
    • Potentialities of skin impedance spectroscopy in vivo in non-invasive monitoring of glucose level

      ea0032p392
    • Association of plasma testosterone concentration with cardiovascular risk factors in young Chinese men of type 2 diabetes mellitus

      ea0032p393
    • Leptin and other adipocins in patients with type 2 diabetes

      ea0032p394
    • Leptin, resistin and omentin in patients with the obesity and with impaired glucose tolerance

      ea0032p395
    • Quality of care in diabetic patients

      ea0032p396
    • Lipid profile of patients newly diagnosed with type 2 diabetes in Albania

      ea0032p397
    • Glycemic and lipid profile in patients with acute pancreatitis

      ea0032p398
    • Practical knowledge about diabetes and the risk of death: 9-year observation

      ea0032p399
    • Blood pressure control in type 2 diabetic patients with overweight or obesity in Guangdong Province: a cross-sectional survey

      ea0032p400
    • The role of a lifestyle modification in preventing type 2 diabetes mellitus and influence it on changes serum leptin levels

      ea0032p401
    • Signs of accelerated carotid atherosclerosis assessed by MRI in newly diagnosed type 2 diabetes

      ea0032p402
    • Cardiovascular risk management in the patients with type 2 diabetes mellitus

      ea0032p403
    • Circulating endothelial progenitor cells as a predictor of clinical outcomes in diabetic patients with symptomatic chronic heart failure

      ea0032p404
    • Correlations between umbilical and maternal adiponectin as well as neonatal birthweight

      ea0032p405
    • The relationship between glycemic control and BNP levels in diabetic patients

      ea0032p406
    • Diagnostic and prognostic value of system matrix mettalloproteinases-1 in patients with diabetes mellitus 2 type

      ea0032p407
    • Fibroblast growth factor 21: a new predictor of cardiovascular events in type 2 diabetes

      ea0032p408
    • Diabetes and hyperglycemia: relation with clinical outcome in the community acquired pneumonia

      ea0032p409
    • iNOS, eNOS, and XOR involvement in hyperglycaemia-induced kidney injury in rats with streptozotocin diabetes mellitus

      ea0032p410
    • Advanced glycation end-products inhibit insulin signaling in human granulosa cells

      ea0032p411
    • Diabetic polyneuropathy course clinical features of patients with various age of diabetes demonstration

      ea0032p412
    • Cardiovascular risk and prevalence of metabolic syndrome in LADA patients depending on thyroid autoimmunity presence

      ea0032p413
    • Endothelial dysfunction in type 2 diabetic patients; its relation with level of albuminuria and frequency of the microvascular complications

      ea0032p414
    • Association between type 1 diabetes and oral health status

      ea0032p415
    • Lower incidence of severe hypoglycaemia during pregnancy in a recent cohort of women with type 1 diabetes followed in a routine care setting

      ea0032p416
    • Association between periodontal disease and vitamin D status in a type 1 diabetic population

      ea0032p417
    • The role of cardio metabolic markers to predict carotid intima media thickness in type 2 diabetic patients

      ea0032p418
    • Improvement in sympathetic cardiac autonomic functions after 6 months of comprehensive yogic breathing program in patients with diabetes

      ea0032p419
    • Relationship between metformin treatment and hyperlactacidemia diagnosed at the emergency room

      ea0032p420
    • Type 1 diabetes and pregnancy: importance of glycemic control in maternal and perinatal outcomes

      ea0032p421
    • Assessment of glycemic control in patients with T1DM and depression

      ea0032p422
    • The peculiarities of atherosclerotic coronary arteries lesion in patients with coronary artery disease and type 2 diabetes mellitus

      ea0032p423
    • The influence of resistin on liver function in patients with diabetes mellitus type 2 and obesity

      ea0032p424
    • Risk factors and outcomes of periferal artery disease in patients with diabetes mellitus

      ea0032p425
    • Early on evaluation of hearing function with transient evoked otoacoustic emissions (TEOAE) and distortion product otoacoustic emissions (DPOAE) in type 2 diabetic patients without hypertension

      ea0032p426
    • Maternal 75 g OGTT glucose levels as predictive factors for large-for-gestational age newborns in women with gestational diabetes mellitus

      ea0032p427
    • The influence of erythropoietin therapy on renal function and proteinuria level in patients with early diabetic nephropathy

      ea0032p428
    • The diabetic hand: a forgotten complication?

      ea0032p429
    • Echocardiographic parameters and blood pressure in normoalbuminuric prehypertensive diabetic patients

      ea0032p430
    • Relationship between endothelin-1 levels in diabetics with and without microangiopathy and control subjects

      ea0032p431
    • Diabetic polyneuropathy predictors

      ea0032p432
    • Endothelial dysfunction in diabetes mellitus

      ea0032p433
    • Risk factors and diabetic foot wound classification: ten years of follow-up

      ea0032p434
    • Smoking and progression of diabetic nephropathy in type 1 diabetes mellitus

      ea0032p435
    • Association of C-reactive protein and nephropathy in type 1 diabetic patients

      ea0032p436
    • Relation of high sensitive CRP and insulin resistance to retinopathy in type 2 diabetes

      ea0032p437
    • Assessment of hypoglycemia risk factors in insulin treated patients

      ea0032p438
    • Admissions of diabetic patients due to hypoglycemia of external cause in a central hospital from 2006 to 2012

      ea0032p439
    • Ambulatory blood pressure profiles in type 2 diabetic patients

      ea0032p440
    • Studying the effect of hypertriglyceridemia and hyperglycemia on the outcome of pregnancy in diabetics and nondiabetics

      ea0032p441
    • Severe diabetic ketoacidosis in type 2 diabetes mellitus

      ea0032p442
    • Disabilities of the arm, shoulder and hand (DASH) questionnaire and diabetic complications: preliminary results

      ea0032p443
    • Impact of a comprehensive management of glycemic profile, arterial hypertension and dislypidemia on the onset of type 2 diabetes mellitus

      ea0032p444
    • Monoballism associated with newly onset ketotic Hyperglycemia

      ea0032p445
    • Comparison of Irbesartan and combination with Nigella sativa oil in experimental diabetic nephropathy

      ea0032p446
    • Association lipids with albuminuria in patients with type 1 diabetes

      ea0032p447
    • Characteristics of the patients treated at the onset of type 2 diabetes mellitus in our Diabetes Day Hospital (DDH) during 2010-2011

      ea0032p448
    • Lipid profile in type 1 diabetic patients in Kragujevac

      ea0032p449
    • Association of type II diabetes mellitus with hepatocelular carcinoma occurrence. A case control study from Western Nepal

      ea0032p450
    • HbA1c levels did not correlate with SF-36 and DQOL scores in patients with poorly controlled type 2 diabetes

      ea0032p451
    • Diabetic ketoacidosis in hospitalized patients with hypertriglyceridemia induced pancreatitis. Case control study

      ea0032p452
    • Deficiency of vitamin D3 in patients with diabetic retinopathy

      ea0032p453
    • A poorly controlled type 2 diabetes complicated by an episode of severe hypertriglyceridemia-induced pancreatitis

      ea0032p454
    • Self care practice among diabetic patients in Kathmandu

      ea0032p455
    • Newly diagnosed diabetic patient presenting with crural infection

      ea0032p456
    • Relation between psychiatric symptoms and diabetic complications: preliminary results

      ea0032p457
    • Pelvic pain in a type 2 diabetes patient

      ea0032p458
    • Marking out group of the increased risk of disorder of the mineralization of the osseous tissue at patients with diabetes

      ea0032p459
    • Postprandial hypotension is attenuable with Acarbose treatment in older adults with diabetes mellitus type 2: a randomized controlled crossover cohort study

      ea0032p460
    • Effect of bariatric surgery on serum glucagon like peptide-1 concentration and metabolic parameters among obese type 2 diabetics

      ea0032p461
    • Ileal interposition with diverted sleeve gastrectomy for treatment of type 2 diabetes

      ea0032p462
    • Clinical usefulness of a bolus calculator in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion (CSII)

      ea0032p463
    • Effects of human insulin and insulin aspart preparations on levels of IGFI, IGFBPs and IGFI bioactivity in patients with type 1 diabetes

      ea0032p464
    • Vitamin B12 deficiency in type 2 diabetic patients on metformin

      ea0032p465
    • Medical staff experience and acceptance of an ICU insulin infusion protocol in a tertiary hospital in the Philippines

      ea0032p466
    • Efficacy and safety of 1 year treatment with Liraglutide in subjects with type 2 diabetes

      ea0032p467
    • Metabolic surgery assessment score (MSAS): a tool to predict diabetes remission after modified bariatric surgery

      ea0032p468
    • No benefit for mortality but advanced risk of hypoglycemia with intensive glucose control in critical care unit brain injured patients: a meta-analysis of RCTs

      ea0032p469
    • Monitoring and control of blood glucose levels in patients with inefficiently controlled insulin-treated diabetes mellitus through the utilization of an on-line telemonitoring system

      ea0032p470
    • Insulin detemir has similar effect when using single daily dose with same dose twice daily as basal insulin therapy with oral antidiabetics.

      ea0032p471
    • Factors related to nonadherence with diabetes treatment among Brazilian type 2 diabetes mellitus patients

      ea0032p472
    • Cardiovascular effects of treatment with Liraglutide in a population with type 2 diabetes

      ea0032p473
    • Therapeutic swicht at discharge improves medium term metabolic control in patients with type 2 diabetes and high vascular risk

      ea0032p474
    • Abstract unavailable

      ea0032p475
    • Impact on weight and glycemic control in patients with type 2 diabetes and obesity treated with liraglutide

      ea0032p476
    • Short-term, temporary insulin degludec, an ultra-long-acting basal insulin, as compared with glargine on the glycemic control in Japanese patients with type 2 diabetes

      ea0032p477
    • Perioperative liraglutide therapy for orthopedic patients with T2DM

      ea0032p478
    • Insulinator: a computer program to help in the insulin therapy

      ea0032p479
    • The long term effect of metformin plus DPP-4 inhibitor switching from metformin plus pioglitazone combination therapy in type 2 diabetes

      ea0032p480
    • Protective effects of Swietenia macrophylla King (seed [amp] endocarp) aqueous-methanolic extract on pancreatic islet histology in streptozotocin-induced diabetic rats

      ea0032p481
    • Are there gender differences in liraglutide response in adults with type 2 diabetes?

      ea0032p482
    • Degree of glycemic control in treated type 2 diabetic patients who live in a district of Madrid, Spain

      ea0032p483
    • Copeptin: may it be a novel biomarker for insulin theraphy in subjects with diabetes?

      ea0032p484
    • Efficacy and safety of liraglutide in morbid obese patients in first year of commercialization in Spain

      ea0032p485
    • Evaluation of adolescents with type 1 diabetes after transition from paediatric to adult care

      ea0032p486
    • Insulin pump therapy as an obligatory treatment modality in a type 2 diabetic patient

      ea0032p487
    • Absence od metformin therapy and inadequate insulin doses are the basic features of diabetic patients with unregulated diabetes

      ea0032p488
    • Analysis of the newly diagnosed diabetic patients, one year and five years of evolution, C-peptide, autoinmunity, treatment and metabolic control

      ea0032p489
    • Assesment of diabetes knowledge evaluation in type 2 diabetic patients

      ea0032p490
    • Advantages of using DPP-4 inhibitors in patients with type 2 diabetes mellitus and overweight

      ea0032p491
    • Hypoglycemic evaluation of Swietenia macrophylla King combined seed and endocarp extracts: a comparative study between hot water extraction and aqueous-methanol extraction

      ea0032p492
    • Evaluation of BICI therapy in pregestational type 1 diabetes

      ea0032p493
    • Quality indicator of glycemic status in patients with diabetes mellitus in primary health care in the Kyrgyz Republic

      ea0032p494
    • Pre-diabetes study in Libya: delay and prevention T2DM

      ea0032p495
    • Molecular docking research analysis of novel natural and synthetic PTP 1B inhibitors as potential therapeutic target for diabetes mellitus

      ea0032p496
  • Endocrine disruptors
  • • Reproductive aging in rats is altered by developmental exposure to mixtures of endocrine disrupters

      ea0032p497
    • An investigation about metabolic disruption: organostannic compounds as PPAR gamma agonists

      ea0032p498
    • Tributyltin changes the thyroid gland morphology of male rats

      ea0032p499
    • Sex hormone-induced gender differences in vascular muscle cells motility are susceptible to the environmental disruptors

      ea0032p500
    • Vitamin E protects against methomyl-induced reproductive toxicity in pregnant female rats

      ea0032p501
    • Bisphenol-A modulates proliferation of human breast adenocarcinoma cells (MCF-7) by modulating apoptosis and cyclin-A

      ea0032p502
    • Protective potential of 17-beta-estradiol on membrane linked functions in aging female rats: a behavioral, biochemical and ultrastructural study

      ea0032p503
    • Effects of chlorobenzenes on the histamine (HA) activated arginine-vasopressin (AVP) release [ndash] from rat pituitary cells

      ea0032p504
    • Rise of obesity incidence in ChNPP accident survivors is related to abnormal secretion of [alpha]-melanotropin

      ea0032p505
    • Endocrine functions in premenopausal and postmenopausal women

      ea0032p506
    • Peutz Jegher syndrome with multiple endocrinal failures

      ea0032p507
  • Endocrine tumours and neoplasia
  • • Heriditary forms of medullary carcinoma of the thyroid: about a new family

      ea0032p508
    • Abstract unavailable

      ea0032p509
    • Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993

      ea0032p510
    • Investigation of novel chemotherapeutic combinations in a tumor model for adrenocortical carcinoma

      ea0032p511
    • Biochemical diagnosis of pheochromocytoma using plasma free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions

      ea0032p512
    • The embryonic transcription factor TBX1 is expressed in adult parathyroid cells and might be involved in parathyroid tumorigenesis

      ea0032p513
    • Characterization and sub-cellular localization of somatostatin receptors in DU-145 and PC-3 human androgen-independent prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growth

      ea0032p514
    • Prevalence of P30L, V281L and P453S mutations of CYP21 gene in patients with nonfunctional adrenal incidentalomas

      ea0032p515
    • Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinoma

      ea0032p516
    • The bone morphogenic proten 7 (Bmp7) plays a pro-tumorigenic role in pheochromocytoma

      ea0032p517
    • Neuroendocrine tumours (NETs) of lung: new data on atypical carcinoid and large cell neuroendocrine carcinoma from a French-Italian multicentric study

      ea0032p518
    • mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids

      ea0032p519
    • Assessment of fatal events in patients with radio-active iodine (RAI)-refractory differentiated thyroid cancer responsive to treatment with sorafenib

      ea0032p520
    • Diagnosis of endogenous hyperinsulinism through arterial calcium stimulation with hepatic venous sampling

      ea0032p521
    • Localization of pathological parathyroids in patients with thyroid abnormalities by PTH measurements in fine needle aspiration biopsy washouts

      ea0032p522
    • Six-years experience in the treatment of the neuroendocrine tumors with the use of peptide receptor radionuclide therapy (PRRT)

      ea0032p523
    • The expression of SSTR dominant negative truncated variant sst5tMD4 influences the effects of SOM-230 on prostate cells in vitro

      ea0032p524
    • Function and origin of tumour-associated fibroblasts (TAFs) in human parathyroid neoplasia

      ea0032p525
    • Expression of FGF23, Klotho, CaSR, and PTHrP in carcinoma in situ and germ cell tumors of the testis: implications for testicular microlithiasis

      ea0032p526
    • The clinical characteristics of primary hyperparathyroidism (PHPT) in patients with multiple endocrine neoplasia (MEN) type 1

      ea0032p527
    • Establishment of patient-individual tumor models for endocrine tumors

      ea0032p528
    • Familial malignant paraganglioma is long-term stabilized with the tyrosine-kinase inhibitor sunitinib

      ea0032p529
    • Insulinoma: is enucleation a safe option?

      ea0032p530
    • Long-term outcome after transarterial chemoembolization of hepatic metastases from neuroendocrine tumors

      ea0032p531
    • Pituitary transforming gene 1 (PTTG1) expression in seminoma

      ea0032p532
    • Polymorphisms of the glucocorticoid receptor gene, as phenotype modifiers in patients with hormonally inactive adrenal adenomas

      ea0032p533
    • Mitochondrial ultrastructure in pseudohypoxic succinate dehydrogenase B and von Hippel-Lindau gene mutation derived pheochromocytomas and paragangliomas

      ea0032p534
    • Adrenal lesions in patients with neuroendocrine tumors

      ea0032p535
    • Association between expression of Ki-67, parafibromin, p27, and Rb protein and the biological behavior in parathyroid tumors

      ea0032p536
    • RPS13 and cell cycle signaling pathways in pituitary tumorigenesis

      ea0032p537
    • Incidental thyroid carcinomas in patients operated on for benign thyroid pathology, are there preoperative factors suggesting a higher risk?

      ea0032p538
    • Involvement of PKC[Beta]; and PKC[Delta]; isoforms in TSH signaling pathway in thyroid cancer cell lines

      ea0032p539
    • PKC[Delta]; plays an important in regulating human medullary thyroid carcinoma cell viability

      ea0032p540
    • Sequential use of the kinase-inhibitors sorafenib and sunitinib in a patient affected with pluri-metastatic iodine-refractory follicular thyroid carcinoma

      ea0032p541
    • Endogenous Cushing's syndrome: the Filipino clinical experience of 19 cases

      ea0032p542
    • Hyperparathyroid jaw tumour syndrome

      ea0032p543
    • Multimodal combination of interferon and loco-regional treatment for disease control in progressive metastatic pheochromocytoma/paraganglioma patients

      ea0032p544
    • The metabolic complications in adrenal tumors: a retrospective study in 56 patients

      ea0032p545
    • Malignant melanoma and prolactine imbalance

      ea0032p546
    • Influence of iron deficiency on angiogenesis in melanoma patients

      ea0032p547
    • Calcitonin comparison study of LIAISON XL vs IMMULITE 2000

      ea0032p548
    • Epidermal growth factor pathway as a possible target in the medical therapy of bronchial carcinoids

      ea0032p549
    • Steroid-induced psychosis as a manifestation of ectopic ACTH secretion from metastatic poorly differentiated neuroendocrine tumour

      ea0032p550
    • Adrenal incidentalomas - a retrospective analysis for the period 2001-2011

      ea0032p551
    • Androgen receptor expression in stromal and epithelial prostate cancer tissue specimens

      ea0032p552
    • Prolactinoma and vestibular schwannoma: a very rare association

      ea0032p553
    • The adverse effects in sub-optimal mitotane doses: a retrospective study

      ea0032p554
    • Type 1 gastric endocrine tumors as an autoimmune disease, with emphasis to lymphocytic thyroiditis

      ea0032p555
    • Acromegaly, primary hyperparathyroidism and meningioma - an unsual association in an asymptomatic patient with MEN1 syndrome

      ea0032p556
    • Aggressive adreno-cortical carcinoma (ACC) associated with two rectal tumors (adenocarcinoma and neuro-endocrine) and somatic Kras mutation without microsatellite instability: is there a link?

      ea0032p557
    • Patient-specific management of paragangliomas

      ea0032p558
    • Malnutrition cause of Secondary Osteoporosis after surgical operation of Glucagonoma

      ea0032p559
    • Clinical, biochemical, genetic and histological features of composite pheochromocytoma/ganglioneuroma adrenal tumors: a series of seven cases from two French academic centres

      ea0032p560
    • Everolimus treatment in a series of patients with advanced neuroendocrine tumors

      ea0032p561
    • Are hibernoma or lipoma a marker of type 1 multiple endocrine neoplasia (MEN1) aggressiveness?

      ea0032p562
    • Malignant pheocromocytoma: vertebral metastasis 18 years after surgery. The importance of prolongued follow-up

      ea0032p563
    • Gastroenteropancreatic neuroendocrine tumors: descriptive study in a reference Spanish hospital

      ea0032p564
    • Extraordinary effect of ketoconazole in treatment of ACTH-dependent paraneoplastic Cushing syndrome

      ea0032p565
    • An analysis of genotype--phenotype correlations and variable clinical expression in families with multiple endocrine neoplasia type 1

      ea0032p566
    • Therapeutic difficulties in elderly patients with insulinoma

      ea0032p567
    • Therapy with 177Lu marked somatostatin analogues in a case of pancreatic metastatic neuroendocrine tumor

      ea0032p568
    • A case of pheochromocytoma that recognized as panic disorder before its exact diagnosis

      ea0032p569
    • Various neuroendocrine tumors in a multiple endocrin neoplasia type 1 family with the same genetic background

      ea0032p570
    • Visceral and tumour abormalities in subjects with acromegaly

      ea0032p571
    • The clinical significance of tumor suppressor gene methylation, expression in nodular thyroid disease

      ea0032p572
    • MEN2A syndrome: case presentation

      ea0032p573
  • Female reproduction
  • • Subcutaneous adipose tissue distribution and metabolic parameters in lean women with polycystic ovary syndrome

      ea0032p574
    • Effect of resistin on LH and FSH stimulated steroidogenesis in porcine ovarian follicles during estrous cycle

      ea0032p575
    • Relation of liver enzymes with indices of insulin resistance and hyperandrogenism in different PCOS phenotypes

      ea0032p576
    • The hinge region of the lutropin receptor mediates different activation mechanisms: CG induces trans- and LH only cis-initialization

      ea0032p577
    • AMHR2 polymorphism and risk for polycystic ovary syndrome: relationship to gonadotropin levels

      ea0032p578
    • White blood cells levels and PCOS: direct and indirect relationship with insulin resistance, but not with hyperandogenemia

      ea0032p579
    • Interactions among resistin and peroxisome proliferator activated receptor-[gamma] (PPAR-[gamma]) in porcine ovarian follicles.

      ea0032p580
    • Differences in adrenocortical steroid response to ACTH in women with post-adolescent severe acne and PCOS

      ea0032p581
    • Ovarian function is associated with obesity in very long-term female survivors of childhood cancer

      ea0032p582
    • New endocrine and intracellular regulators of ovarian functions

      ea0032p583
    • Deletions of TCF2 gene in Rokitansky syndrome (MRKH): a new candidate gene? About two new cases

      ea0032p584
    • Thrombin generation in polycystic ovary syndrome: a marker of thrombosis

      ea0032p585
    • The combination of genetic variants in the FSHR and FSHB genes affect serum FSH in women of reproductive age

      ea0032p586
    • The hypothalamo--pituitary--adrenal axis sensitivity in women with polycystic ovary syndrome

      ea0032p587
    • Value of lipid accumulation product for the assessment of metabolic syndrome in women with polycystic ovary syndrome

      ea0032p588
    • The assessment of metabolic derangements including metabolic syndrome in relation to the degree of hyperandrogenism in women with polycystic ovary syndrome

      ea0032p589
    • Gynecological aspects of prolactinoma

      ea0032p590
    • Levonorgestrel inhibits human endometrial cell proliferation through the up-regulation of gap junctional intercellular communication via the increased expression of Connexin43 and the nuclear translocation of its Ser255 phosphorylation

      ea0032p591
    • Overnight 1 mg dexamethasone androgen suppression test is useful diagnostic tool in hyperandrogenism.

      ea0032p592
    • Low dose oral contraceptive use and the risk of thrombosis in polycystic ovary syndrome

      ea0032p593
    • PCOS subphenotypes stratification reveals an apparent increase of metabolic syndrome frequency in patients with concomitant hyperandrogenism and menstrual irregularities

      ea0032p594
    • Association of serum 25-hydroxyvitamin D and glucose levels in polycystic ovary syndrome

      ea0032p595
    • Prevalence of prediabetes state is not equal in all phenotypes of polycystic ovary syndrome

      ea0032p596
    • Metabolic features in patients with polycystic ovary syndrome (PCOS) during different stages of reproductive life

      ea0032p597
    • Association of thyroid autoimmunity and thyroid dysfunction with obstetric antiphospholipid syndrome

      ea0032p598
    • Inflammatory markers in polycystic ovarian syndrome and their association with cardiovascular risk factors

      ea0032p599
    • The effect of metformin on pregnancy outcome among filipino women with polycystic ovary syndrome

      ea0032p600
    • Flutamide-induced alterations in CYP17A1 gene expression and local testosterone synthesis in porcine luteal tissue - a new insight into androgens action during pregnancy

      ea0032p601
    • Relation of adiponectin and leptin to antropometric and metabolic parameteres in women with polycystic ovaries syndrome

      ea0032p602
    • PON1-108 TT and PON1-192 RR genotypes are more frequently encountered in Greek PCOS than non-PCOS women, and are associated with hyperandrogenemia

      ea0032p603
    • C-reactive protein and gestational diabetes mellitus

      ea0032p604
    • Ovarian functions and polycystic ovary syndrome in women with type 1 diabetes mellitus

      ea0032p605
    • Concordance study of pathological results of fertility hormones

      ea0032p606
    • Main determinants of serum uric acid concentrations in polycystic ovary syndrome patients

      ea0032p607
    • Vitamin D level in polycystic ovary syndrome patients is not different from healthy control in Turkish population

      ea0032p608
    • Prevalence of polycystic ovary syndrome in infertile patients in Albania

      ea0032p609
    • Association of advanced glycosylation end products receptor polymorphisms with coronary heart disease in postmenopausal women

      ea0032p610
    • Association of gonadotroph pituitary macroadenoma and contiguous brain chordoma in a young woman with ovarian hyperstimulation syndrome

      ea0032p611
    • Menstrual function in women of reproductive age with acromegaly

      ea0032p612
    • Mechanisms of menstrual disorders in type1 diabetic women

      ea0032p613
    • Mitochondrial function of pregnant women with subclinical hypothyroidism and gestational hypertension

      ea0032p614
    • Hormonal disorders and breast diseases in adolescent girls

      ea0032p615
    • Menstrual cycle length is associated with metabolic syndrome in young Korean women with oligomenorrhea

      ea0032p616
    • Obstructive sleep apnea in Bulgarian patients with polycystic ovarian syndrome

      ea0032p617
    • Plasma kisspeptin levels in polycystic ovary syndrome

      ea0032p618
    • Relation of plasma kisspeptin levels with obesity and insulin resistance in polycystic ovary syndrome

      ea0032p619
    • Potential discriminant factors for different pcos phenotypes

      ea0032p620
  • Growth hormome IGF axis – basic
  • • Delay stature and shox gene molecular abnormalities: about 4 families

      ea0032p621
    • A comparison of the in vitro production of IGFs, IGFBP-4 and PAPP-A in cultures of visceral and subcutaneous adipose tissue fragments from obese subjects

      ea0032p622
    • Low extracellular sodium causes neuronal distress independently of reduced osmolality in an experimental model of chronic hyponatremia

      ea0032p623
    • Association between a common GH receptor polymorphism (exon 3-deletion), pre- and postnatal growth, serum insulin-like growth factor 1 and reproductive function in 838 healthy young males

      ea0032p624
    • SNPs within the GH signaling pathway are associated with the fast, but not the long term, IGF1 response to GH replacement therapy in GH deficient adults

      ea0032p625
    • Pilot study of nocturnal TSH surge in idiopathic short stature

      ea0032p626
    • Preclinical characterisation of NNC0195-0092, a long-acting GH

      ea0032p627
    • Sheehan's syndrome females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors

      ea0032p628
    • Determinants of carotid intima media thickness in acromegaly patients

      ea0032p629
    • First results from the PATRO adults study of omnitrope for the treatment of adult patients with GH deficiency

      ea0032p630
    • GH therapy in Turner syndrome: growth rate indirectly correlated with age of therapy initiation

      ea0032p631
    • Glucose metabolism abnormalities in a population of acromegalic patients

      ea0032p632
    • Evaluation of LIAISON XL vs IMMULITE 2000 IGF1

      ea0032p633
    • GH therapy: never say never; clinical case

      ea0032p634
    • Silver-Russell syndrome about 15 cases and review of literature

      ea0032p635
    • Neuroendocrine disorders and anomalies of median line: about two cases

      ea0032p636
  • Male reproduction
  • • KISS1R mutations in normosmic congenital hypogonadotropic hypogonadism: clinical evaluation of two families and molecular characterization of a novel mutation

      ea0032p637
    • Strength training and testosterone treatment have opposing effects on migration inhibitor factor levels in ageing men

      ea0032p638
    • Decreased expression of four memory genes in non-syndromic cryptorchid males

      ea0032p639
    • Complete aromatase deficiency in four adult men: detection of a novel mutation and two known mutations in the CYP19A1 gene

      ea0032p640
    • Mortality is increased in men treated with testosterone compared to age and sex-matched controls

      ea0032p641
    • Seminal, ultrasound and psychobiological parameters correlate with metabolic syndrome in male members of infertile couples

      ea0032p642
    • Effects of iron therapy on pituitary gonadal axis and sperm parameters in adults with iron deficiency anemia (IDA)

      ea0032p643
    • Endocrine disruptors target ATP binding cassette transporters in the blood-testis barrier and impair Leydig cell steroidogenesis

      ea0032p644
    • Prenatal testosterone programming: ontogeny of changes in testis of fetal and prepubertal male sheep

      ea0032p645
    • Androgen levels and sexual activity in young men (n=773), 20-29 years of age, a population based study. Odense Androgen Study

      ea0032p646
    • Abstract unavailable

      ea0032p647
    • Characterization of sumoylated proteins in human sperm

      ea0032p648
    • Characterization of R31C GNRH1 mutation in congenital hypogonadotropic hypogonadism

      ea0032p649
    • Abstract unavailable

      ea0032p650
    • Sexual dysfunction in cirrhotic patients awaiting liver transplantation

      ea0032p651
    • Fifteen years of experience with intramuscular testosterone undecanoate for substitution in male hypogonadism: beneficial effects on the metabolic syndrome and high safety profile

      ea0032p652
    • Metabolic syndrome correlates with prostate volume and biochemical and ultrasound signs of prostate inflammation in male members of infertile couples

      ea0032p653
    • Identification of vitamin D (VDR) and retinoic X (RXR) receptor in normal and neoplastic human reproductive tissues

      ea0032p654
    • Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation

      ea0032p655
    • CATSPER calcium channels in human spermatozoa and their role in responsiveness to progesterone (P)

      ea0032p656
    • Impaired masturbation induced erections: a new cardiovascular risk factor for male subjects with sexual dysfunction

      ea0032p657
    • PSA as a marker of testosterone biological activity

      ea0032p658
    • Effects of testosterone replacement therapy on hepcidin levels in young hypogonadal men

      ea0032p659
    • D3 levels and hypogonadism in men

      ea0032p660
    • Changes of neuroactive steroids caused by the smoking discontinuance

      ea0032p661
    • Testosterone undecanoate 1000 mg at 3 months does not increase prostatic specific antigen level: study on over 100 patients, December 2012

      ea0032p662
    • Analysing by decade, testosterone undecanoat depot injectable does not increases prostate volume. Study during up to 6 years on hypogonadic patients

      ea0032p663
    • Male pseudohermaphroditism Leydig cell hypoplasia

      ea0032p664
    • Immunohistochemical detection of Prok1 and ProkR1 in normal testis and germ cell tumour tissue microarrays

      ea0032p665
    • Endocrine disruptors in seminal fluid: bisphenol A, triclosan and benzophenone-3

      ea0032p666
    • Sperm DNA fragmentation as assessed by TUNEL/PI: mean values in fertile men and intra individual variability

      ea0032p667
    • The identification of pre-diabetes condition with ARIC algorithm, predicts long-term CV events in patients with erectile dysfunction

      ea0032p668
    • Is pericentromeric inversion of the heterochromatic region of chromosome 9 involved in couple infertility?

      ea0032p669
    • The hypothalamus-hypophysis-gonads axis in men in reproductive age with obesity and different pituitary adenomas

      ea0032p670
    • A case of idiopathic hypogonadotropic hypogonadism which attained remission by LH and FSH treatment

      ea0032p671
    • Risk factors associated with primary and secondary reduced libido in male patients with sexual dysfunction

      ea0032p672
    • The role of testosterone augmentation in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) in improving functional recovery and hospital stay

      ea0032p673
    • Fourty six, XX male sex reversal syndrome with infertility: a case report

      ea0032p674
    • Investigation on psychological symptoms improves ANDROTEST accuracy in predicting hypogonadism in subjects with sexual dysfunction

      ea0032p675
    • Two unconventional risk factors for major adverse cardiovascular events in subjects with sexual dysfunction: low education and reported partner's hypoactive sexual desire in comparison with conventional risk factors

      ea0032p676
    • 'It takes two to tango': the relational domain in a cohort of subjects with erectile dysfunction (ED)

      ea0032p677
  • Neuroendocrinology
  • • Genotype and phenotype characterization of the cohort of Italian patients with idiopathic central hypogonadism (ICH)

      ea0032p678
    • DHEA enhances working memory and prevents distraction: behavioural and ERP evidence from an auditory-visual distraction paradigm

      ea0032p679
    • High glucose induces hypogonadotropic hypogonadism by interfering with GPR54 signaling in the preoptic area of the hypothalamus

      ea0032p680
    • Hypothalamic melanin-concentrating hormone influences liver and adipose lipid metabolism

      ea0032p681
    • Hormonal therapy satisfaction is associated with better quality of life in transsexual persons

      ea0032p682
    • The small GTPase Rab18 modulates neuroendocrine secretion by interacting with components of the microtubule-based secretory granule transport machinery

      ea0032p683
    • Roles of kisspeptin partners, NKB and dynorphin, in the control of gonadotropin secretion: revisiting the KNDy paradigm

      ea0032p684
    • Antipsychotic-induced hyperpolactinemia: clinical particulars and relation to sexual dysfunction

      ea0032p685
    • Low carbohydrate/high fat energy intake decreases estrogen receptor alpha expression in the arcuate nucleus of the rat hypothalamus

      ea0032p686
    • Digenic and oligogenic cases in a large cohort of idiopathic central hypogonadism (ICH) patients

      ea0032p687
    • The characterization of sleep-wake pattern and its association with melatonin, as a marker of the circadian function of the suprachiasmatic nucleus, in craniopharyngioma patients

      ea0032p688
    • Pituitary adenoma and associated tumors

      ea0032p689
    • Iron overload impairs the migratory ability of a model of immature and migratory GnRH neurons

      ea0032p690
    • The reproductive endocrine complications of antiepileptic drugs at woman's epilepsy

      ea0032p691
    • DHEA and cortisol response to working memory

      ea0032p692
    • Neuroprotective effects of estrogen rely on neuroglobin upregulation

      ea0032p693
    • Diagnosis and management of patients presenting hyponatremia while receiving parenteral nutrition

      ea0032p694
    • Des-acyl ghrelin acts directly and independently and counteracts acyl-ghrelin-induced neuronal activity in the central melanocortin system of rats

      ea0032p695
    • Evaluation of the efficacy of midnight salivary cortisol plus dexamethasone suppression test as screening for the diagnosis of hypercortisolism within an at-risk population

      ea0032p696
    • Impact of long acting somatostatin analogs vs successful surgery on glucose metabolism in Cretan acromegalic patients

      ea0032p697
    • Prevalence and causes of hyponatremia in patients with endocrine disorders

      ea0032p698
    • Acute exposure of Bisphenol-A from electronic gadgets does not induce oxidative stress in the rat's brain

      ea0032p699
    • Oxytocin modulates olfaction-related behaviour and essential for onset of sexual behaviour in both sexes of mice

      ea0032p700
    • Obestatin is associated to muscle strength, functional capacity and cognitive status in old women

      ea0032p701
    • Copeptin for subtype differentiation of abnormal vasopressin release in SIADH: reclassification and characterization of a novel subtype

      ea0032p702
    • Neurodegenerative and inflammatory biomarkers in cerebrospinal fluid in patients with Cushing's syndrome

      ea0032p703
    • Evaluation of GH deficiency and central adrenal insufficiency in patients following craniospinal irradiation in young ages: comparison between the glucagon stimulation test and the insulin tolerance test

      ea0032p704
    • Diurnal melatonin profile in patients with acromegaly

      ea0032p705
    • Comparative analysis of the hormonal, MRI and morphological characteristics of patients with Cushing's disease remission and no remission after neurosurgical treatment

      ea0032p706
    • Prevalence and clinical significance of hook-effect and macroprolactinaemia phenomenons in patients with prolactinomas

      ea0032p707
    • Hyponatremia in the emergency room: characteristics, and initial diagnostic approach

      ea0032p708
    • Modulation of Na+/K+-ATPase activity of rat brain synaptosome by norepinepherine and serotonin

      ea0032p709
    • Adulthood germ cell tumor: a case report

      ea0032p710
    • Infrasellar gangliocytoma causing cushing's disease: a case report

      ea0032p711
    • Effects of GH therapy in carbohydrate metabolism in spanish adults with GH deficiency

      ea0032p712
    • Clinical case of silent corticotropinoma

      ea0032p713
    • Central diabetes insipidus, as the first sign of Langerhans cell histiocytosis in an adult

      ea0032p714
    • RET codon 618 mutation is the most frequent genotype in saudi families with multiple endocrine neoplasia type 2a and familial medullary thyroid carcinoma

      ea0032p715
    • Neurological manifestations of Vitamin D deficiency, is there any significant clinical correlation?

      ea0032p716
    • Craniopharyngioma -- a diagnosis not to be missed

      ea0032p717
    • Features of family inheritance in patients of non-functional pituitary adenomas in Uzbekistan

      ea0032p718
    • Abstract unavailable

      ea0032p718.1
  • Nuclear receptors and signal transduction
  • • The nuclear corepressor NCoR is an essential mediator of the anti-tumorigenic and anti-metastatic actions of the thyroid hormone receptor

      ea0032p719
    • Coordination of 17[beta]-estradiol-dependent cell proliferation requires diverse post-translational modifications

      ea0032p720
    • Non-proteolytic ubiquitin-based signalling regulates estrogen receptor [alpha] activities

      ea0032p721
    • The thyroid hormone receptors inhibit invasive and fibrotic responses to TGF[beta] by transcriptional cross-talk with smad-transcription factors

      ea0032p722
    • 5/6 Nephrectomy reduces muscle mitochondria in mice as to decrease exercise endurance associated with further exacerbation by dietary protein

      ea0032p723
    • Effects of Tribulus terrestris on immune function in over-trained rats and its mechanism: the role of glucocorticoid and glucocorticoid receptor

      ea0032p724
    • Nuclear receptor 'master' coactivators of physiology and pathology

      ea0032p725
  • Obesity
  • • The lack of Nur77 affects energy and glucose metabolism in females fed on high fat diet

      ea0032p726
    • Abstract unavailable

      ea0032p727
    • Serum- and glucocorticoid-regulated kinase 1 in obesity-related adipose tissue and peripheral inflammation

      ea0032p728
    • New insights on molecular mechanisms regulating hepatic sex hormone-binding globulin production: clinical implications in obesity and type 2 diabetes

      ea0032p729
    • Obesity: a paradox in the mortality of the elderly

      ea0032p730
    • Brite adipocytes: a role for cannabinoid receptor type 1 in brown adipose cell recruitment

      ea0032p731
    • Metabolic side effects of second generation antipsychotic drugs in adolescents

      ea0032p732
    • Gastric banding vs gastric bypass: evolution of anthropometric parameters and related comorbidities during the 2 years after surgery

      ea0032p733
    • Obesity-induced hepatic and placental inflammation are absent in obese gestating mice compared to control fed dams

      ea0032p734
    • Serum IL18 concentration is associated with resting energy expenditure independently of BMI

      ea0032p735
    • High fat diet induces site specific resistance to LPS-stimulated STAT3 activation in the CNS

      ea0032p736
    • Association of mitochondrial respiratory chain polymorphisms with obesity and type 2 diabetes in the Spanish population

      ea0032p737
    • The FXR agonist obeticholic acid normalizes lipid droplet and triglyceride handling in visceral adipose tissue preadipocytes from a non-genomic rabbit model of metabolic syndrome

      ea0032p738
    • Corticotrophin realising factor affects the immune phenotype of adipocytes via CRF1 and CRF2 receptors

      ea0032p739
    • Obese hypogonadal men treated with testosterone undecanoate injections up to 5 years substantially and progressively lose weight

      ea0032p740
    • Consumption of low-carbohydrate/high fat diets impairs glucose tolerance in rats independent of changes in body composition

      ea0032p741
    • Depression and suicidal ideation among adults with metabolic syndrome: data from the 2008--2010 Korea national health and nutrition examination survey

      ea0032p742
    • Early changes in glucose, insulin, C-peptide and GLP-1 levels after test meal in obese patients after gastric bypass surgery

      ea0032p743
    • Modulation of gene expression by 3-iodothyronamine: evidence of a lipolytic pattern

      ea0032p744
    • Evaluation of gastric bypass effect on cardiovascular risk and quality of life in our area

      ea0032p745
    • Green tea catechins attenuate high-fat diet effects related to obesity and diabetes without effect hypothalamic expression of TLR4 pathway or serotoninergic 1B and 2C receptors

      ea0032p746
    • Short-term ovariectomy did not cause tissues proinflammatory state, but associated with hyperlipidic diet caused hyperleptinemia and increased body weight gain

      ea0032p747
    • Differences among clinical, analytical and psychological outcomes among patients with an eating disorder after bariatric surgery

      ea0032p748
    • BMI as a prognostic feature in patients with breast cancer treated with chemo/endocrine therapy

      ea0032p749
    • Osteocalcin: more than a bone marker: the Odense Androgen Study

      ea0032p750
    • Associations between smoking and components of the metabolic syndrome

      ea0032p751
    • Monocyte chemoattractant protein-1 is associated with apolipoprotein A-I and apolipoprotein e levels in obese premenopausal women

      ea0032p752
    • Chronic central administration of amylin decreases fat mass but does not modify body weight

      ea0032p753
    • Apelin levels in men with metabolic syndrome with or without late-onset hypogonadism

      ea0032p754
    • Apnoeic episodes impair insulin resistance independently of oxygen desaturations: evidence from morbid obese patients with discordant apnoea/desaturation indexes

      ea0032p755
    • Circulating endocannabinoids are differentially modulated during the oral glucose tolerance test

      ea0032p756
    • Adiponectin and leptin actions on DNA synthesis and cell death of porcine myoblasts are dependent on the cellular milieu and related to ERK1/2 signalling

      ea0032p757
    • Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a meta-analytic study

      ea0032p758
    • Serum levels of fetuin A and 8-hydroxydeoxyguanosine in morbidly obese subjects

      ea0032p759
    • Off-label GLP-1 agonist treatment in 43 non-diabetic patients: are weight loss and treatment tolerance equally promising outside of clinical trials?

      ea0032p760
    • SHBG and testosterone are associated with inflammation in obese men

      ea0032p761
    • The effect of rutin on homocysteine induced proliferation of 3T3-L1 preadipocyte in vitro

      ea0032p762
    • Preoperative metabolic status is associated with adiponectin levels attained 6 months after laparoscopic sleeve gastrectomy, independently of the degree of weight loss

      ea0032p763
    • Evaluation of gastric bypass effect on cardiovascular risk and quality of life in type 2 diabetes patients

      ea0032p764
    • Evaluation of the prevalence of obesity and overweight in the Belarus within the Framework of the National Campaign 'Early Detection and Prevention of Type 2 Diabetes Mellitus'

      ea0032p765
    • No long-term weight reduction after gastric banding (LAGB) in obese patients with craniopharyngioma involving hypothalamic structures: experiences from KRANIOPHARYNGEOM 2000

      ea0032p766
    • Long-term weight development and psychosocial status in childhood craniopharyngioma patients

      ea0032p767
    • Assessment of dietary habits in obese patients

      ea0032p768
    • Sub clinical hypercortisism in patients with metabolic syndrome

      ea0032p769
    • Testosterone concentrations in obesity, an outcome of lipotoxicity?

      ea0032p770
    • Hypogonadal men receiving testosterone treatment for 5 years had significant and clinically meaningful reductions in weight and waist circumference

      ea0032p771
    • Moderating role of cognitive ability on the obesity: inflammation: insulin resistance triplet

      ea0032p772
    • Should all the obese patients be screened for Cushing's syndrome?

      ea0032p773
    • Diabetes remission after bariatric surgery may be jeopardized by remission criteria and previous hypoglycemic treatment

      ea0032p774
    • Should remission of type 2 diabetes mellitus be the foremost goal after bariatric surgery?

      ea0032p775
    • Development of metabolic syndrome is influenced by the thyroid function and age

      ea0032p776
    • Frequency of attention-deficit/hyperactivity disorder (ADHD) in a bariatric post surgery sample: clinical, analytical and psychological differences among bariatric patients with ADHD criteria

      ea0032p777
    • Do the association of phthalates and some parameters of obesity persist? Pilot study

      ea0032p778
    • 'Diabesity' in women: the EEM study

      ea0032p779
    • The medical and moral obligation of healthcare professionals to address complications in obesity during pregnancy

      ea0032p780
    • Circulating adiponectin as marker of obesity-induced chronic low grade inflammation

      ea0032p781
    • Prevalence of obesity, diabetes and prediabetes in Tirana, the capital of Albania 2010[ndash]2011

      ea0032p782
    • Madelung's disease: a case report

      ea0032p783
    • PTH one year after gastric bypass in morbidly obese patients

      ea0032p784
    • Neck circumference association with metabolic risk factors in patients undergoing neck surgery

      ea0032p785
    • Rapid reversal of hyperglycemia despite modest weight loss in a patient post gastric bypass surgery: a case report and review of the literature

      ea0032p786
    • Insulinresistance at obesity and diabetes

      ea0032p787
    • Lean mass and fat mass distribution in Ukrainian women with metabolic syndrome in postmenopausal period

      ea0032p788
    • Lean and fat mass in Ukrainian women of different age

      ea0032p789
    • Dieting attitudes among college students in Romania

      ea0032p790
  • Paediatric endocrinology
  • • GH treated children with IGF1 deficiency and excluded GH insensitivity despite normal GH secretion may attain similar final height as children with GH deficiency

      ea0032p791
    • Reference curves for body fat (%) for Danish children evaluated by skinfolds and dual-energy X-ray absorptiometry

      ea0032p792
    • Abnormalities in growth and in the IGF system can be associated to permanent chronic inflammatory process in HIV-infected children independently of clinical control

      ea0032p793
    • Unaltered sex steroid levels, but elevated serum IGF1 in healthy boys with pubertal gynaecomastia

      ea0032p794
    • Metabolic syndrome in adolescents and young adults with childhood-onset GH deficiency

      ea0032p795
    • Premature pubarche: distinguishing between nonclassic congenital adrenal hyperplasia and idiopathic premature adrenarche

      ea0032p796
    • Improvement in metabolic control of type 1 diabetes mellitus in a tertiary unit: 2005 vs 2012

      ea0032p797
    • Subclinical hypothyroidism in obese children: the influence of L-thyroxin treatment on metabolic comorbidities and a success of dietary therapy

      ea0032p798
    • Urinary phthalates from 168 girls and boys measured twice a year during a 5-year period: associations with adrenal androgen levels and puberty

      ea0032p799
    • Hormonal and auxological data of the patients with persistent and transient GH deficiency, diagnosed according to different criteria after completion of growth-promoting therapy

      ea0032p800
    • Adipocyte dysfunction in pediatric obesity

      ea0032p801
    • GnRH analog treatment in children with congenital adrenal hyperplasia complicated by central precocious puberty

      ea0032p802
    • Growth and pubertal development in adolescent male wrestlers

      ea0032p803
    • GH therapy and effect on ovarian function and morphology in short prepubertal SGA girls

      ea0032p804
    • GH dynamics in oral glucose tolerance test in children and adolescents with tall stature

      ea0032p805
    • Obesity and thyroid function in children: cross-sectional study

      ea0032p806
    • Final height of a group of patients with congenital adrenal hyperplasia

      ea0032p807
    • Sex steroid priming in differential diagnosis between idiopathic GH deficiency and constitutional delay of growth and puberty

      ea0032p808
    • Importance of gastroenterologist in successful recovery of anorexia nervosa patients

      ea0032p809
    • Primary amenorrhea aetiologies: results from a monocenter study

      ea0032p810
    • Serum levels of 25(OH)-vitamin D and adipokine's profile in obese children and adolescents

      ea0032p811
    • Hepatic function in Berardinelli[ndash]Seip patients

      ea0032p812
    • An adolescent girl with hypothyroid coma due to autoimmune thyroiditis

      ea0032p813
    • Features of hyperprolactinemia syndrome in children

      ea0032p814
    • Growth disorders in Greece: baseline data from a multicentre observational study (GENESIS)

      ea0032p815
    • Predicting growth response among Egyptian idiopathic isolated GH deficient children

      ea0032p816
    • Williams syndrome: report of a case

      ea0032p817
    • Case report: two patients with Di George syndrome with different diagnostic peculiarities

      ea0032p818
    • Egyptian GH deficient patients: demographic, auxologixcal characterization and response to GH therapy

      ea0032p819
    • Male pseudo hermaphrodism due to the association of two very rare conditions: a deficit in 17[beta]-hydroxysteroid dehydrogenase type 3, and a chimerism

      ea0032p820
    • Results of investigation of children and adolescents (boys) with different disorders of puberty development in Bukhara city and four districts (Republic of Uzbekistan)

      ea0032p821
    • Hormonal results of investigation of adolescents (boys) with delay of puberty

      ea0032p822
  • Pituitary–Basic (Generously supported by IPSEN)
  • • Gene expression profiling of familial and sporadic pituitary adenomas

      ea0032p823
    • Role of filamin-A in the regulation of SST2 receptor localization and signalling in tumoral GH-secreting cells

      ea0032p824
    • Drosophila melanogaster as a model organism to study aryl hydrocarbon receptor interacting protein gene function

      ea0032p825
    • The role of GLI1 in pituitary tumor formation and pituitary cell survival

      ea0032p826
    • cAMP exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A and exchange proteins directly activated by cAMP

      ea0032p827
    • Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 pituitary adenomas, using immunohistochemical detection with specific MABs

      ea0032p828
    • mTOR mediated IGF1 proliferative effects on a rat pituitary GH/PRL secreting pituitary adenoma cell line

      ea0032p829
    • Mutations of SOX2 gene: a novel heterozygous mutation and impact on congenital hypopituitarism

      ea0032p830
    • Chracterizazion of somatostatin receptor expression in MENX-assoxciated pituitary adenomas: impact on therapy and imaging with somatostatin analogs

      ea0032p831
    • Clinical and morphological characteristics of dopamine agonist-resistant prolactinomas

      ea0032p832
    • Expression of connexins 26, 32 and 43 mRNA in normal and pituitary adenomas

      ea0032p833
    • No correlation between somatostatine 2 receptor expression analyzed by RNA in-situ hybridization and real-time qRT-PCR in clinically non-functioning pituitary adenomas

      ea0032p834
    • FSH and LH cells in normal-fed male rats after centrally applied ghrelin

      ea0032p835
    • PTTG and Ki-67 expression in pituitary adenomas

      ea0032p836
    • Medical therapy of acromegaly

      ea0032p837
    • Daidzein affects the stereological parameters of pituitary GH cell in orchidectomized adult rat

      ea0032p838
    • 8-Prenylnaringenin decreases hormone expression in GH3 pituitary adenoma cells of the rat

      ea0032p839
  • Pituitary – Clinical (Generously supported by IPSEN)
  • • Early and sustained tumour volume reduction and GH/IGF1 control in patients with GH-secreting pituitary macroadenoma primarily treated with lanreotide Autogel 120 mg for 48 weeks: the PRIMARYS study

      ea0032p840
    • The benefits of pasireotide in patients with Cushing's disease are not restricted to patients with normalisation of UFC; results from a large, 12-month study

      ea0032p841
    • Exploration of hand size as a screening tool for acromegaly

      ea0032p842
    • The results of sandostatin LAR therapy in acromegalic patients

      ea0032p843
    • Spanish molecular registry of pituitary adenomas: a multicenter, translational approach aimed at improving patient management

      ea0032p844
    • Pasireotide LAR and octreotide LAR maintain inhibition of GH and IGF1 in patients with acromegaly: 12-month extension phase of a randomized, double-blind, multicenter, phase III study

      ea0032p845
    • Characteristics of patients with pituitary gigantism: results of an international study

      ea0032p846
    • Switching patients with acromegaly from octreotide LAR to pasireotide LAR improves biochemical control: crossover extension to a randomized, double-blind, multicenter, Phase III study

      ea0032p847
    • Advanced glycation end product associated skin autofluorescence and serum corboxymethyl lysine levels in acromegaly

      ea0032p848
    • The prevalence of insufficient test responses in patients with traumatic brain injury compared to healthy controls [ndash] results from The Danish National Study on posttraumatic hypopituitarism

      ea0032p849
    • Endoscopic transsphenoidal approach as a promising surgical option in the treatment of craniopharyngioma

      ea0032p850
    • A precocious GH peak at GHRH plus arginine test in GH sufficient short children is predictive of a lower growth velocity

      ea0032p851
    • A novel mutation in gonadotropin releasing hormone receptor causing delay in puberty in a sporadic case of isolated hypogonadotropic hypogonadism

      ea0032p852
    • Evaluation of late-night salivary cortisol during a Phase III study with pasireotide in patients with Cushing's disease

      ea0032p853
    • Evaluation of long-term pituitary functions after hypoxia due to ventricular arrhythmias: a preliminary report

      ea0032p854
    • Long-term efficacy of long-acting somatostatin analogues in combination with pegvisomant in 112 acromegaly patients, a retrospective single centre study with follow up for up to 8 years

      ea0032p855
    • Long-term safety of long-acting somatostatin analogues in combination with pegvisomant in 133 acromegalic patients, a retrospective single centre study with follow up for up to 8 years

      ea0032p856
    • Similar response to therapy of pituitary adenomas with and without SOX2-expressing cells

      ea0032p857
    • The clinical characteristics of pain in patients with pituitary adenomas

      ea0032p858
    • Genetic and clinical characteristics of Serbian FIPA families

      ea0032p859
    • Doubled mortality ratio in female patients with non-functioning pituitary adenomas

      ea0032p860
    • Incidentally discovered pituitary adenomas: single-center experience on 205 patients

      ea0032p861
    • Clinical diagnostic implications of sequential pattern of dynamic MRI for pituitary microadenoma

      ea0032p862
    • How to get surgical remission rates in ACTH- and GH-microadenomas to 100%

      ea0032p863
    • Moderate hyponatremia is associated with an increased risk of overall mortality: a comprehensive meta-analysis

      ea0032p864
    • Effects of somatostatin analogues on muscle sympathetic nerve activity in acromegaly

      ea0032p865
    • Effects of short (12 months) and long (60 months) term treatment with cabergoline on metabolic syndrome and visceral adiposity index in patients with hyperprolactinemia

      ea0032p866
    • Real world data in acromegaly - a retrospective chart audit

      ea0032p867
    • Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study

      ea0032p868
    • The effect of the ANKK1/DRD2 Taq1A polymorphism on metabolic side effects of dopaminergic treatment in PRL adenomas

      ea0032p869
    • Incidental haemorrhage in prolactinomas: is it of any clinical significance?

      ea0032p870
    • Incidence of pituitary adenomas in Western Sweden in 2001-2011

      ea0032p871
    • Ursodeoxycholic acid role in chronic cholecystitis progression prevention in acromegaly patients receiving somatostatin analogues

      ea0032p872
    • Relationship between telomere length and dyslipidemia in patients with Cushing's syndrome

      ea0032p873
    • Factors Affecting Prognosis in a Series of Acromegalic Patients

      ea0032p874
    • Thirty-day mortality in acute non-surgical patients admitted with hyponatremia

      ea0032p875
    • Metabolic impact of IGF(CA)19 gene polymorphism on the response to GH therapy in adult GH-deficient (GHD) patients

      ea0032p876
    • Hypopituitarism after fractionated stereotactic radiation therapy of anterior skull base meningiomas is caused by mass effects, not radiation

      ea0032p877
    • Role of IGF(CA)19 gene polymorphism in the clinical presentation of acromegaly

      ea0032p878
    • Relationship between early endocrine alterations and functional outcome in patients with severe brain injury

      ea0032p879
    • Limitations of basal IGF-1 status reflecting the severity of growth hormone deficiency and predicting response to replacement therapy

      ea0032p880
    • Effects of gender and body composition on GH response to GHRH+Arg in HIV-lipodystrophic patients: higher rate of GH deficiency in men

      ea0032p881
    • Obesity in patients with craniopharyngioma seems to be caused by eating disorders rather than changes in mood or activity

      ea0032p882
    • Correlation of clinical smell test and magnetic resonance imaging of olfactory system in idiopathig hypogonadotropic hypogonadism

      ea0032p883
    • Diencepephalic syndrome before diagnosis of childhood craniopharyngioma: results of multinational studies on 485 long-term survivors after childhood craniopharyngioma

      ea0032p884
    • Xanthogranuloma, Rathke's cyst, and Childhood Craniopharyngioma: results of prospective multinational studies of children and adolescents with rare sellar malformations

      ea0032p885
    • Short-term exercise-induced GH response in athletes: differential results for runners and bikers when tested on bicycle

      ea0032p886
    • Gender determines ACTH recovery after experimental hypercortisolemia in older individuals

      ea0032p887
    • Levels of prolactin, FSH and LH pool vs single sample determination

      ea0032p888
    • Tumors with simultaneous hypersecretion of somatotropin and prolactin are associated with earlier diagnosis compared with tumors with isolated hysecretion of somatotropin

      ea0032p889
    • Macroprolactinomas: dopamine agonists for how long?

      ea0032p890
    • Role of reversal of hypogonadism on the improvement of metabolic syndrome in male patients with hyperprolactinemia during chronic treatment with cabergoline

      ea0032p891
    • Measurement of hGH in acromegalic patients under pegvisomant treatment

      ea0032p892
    • Myeloproliferative neoplasms in patients with acromegaly

      ea0032p893
    • Familiar panhypopituitarism by a mutation in PROP1: four of seven brothers affected

      ea0032p894
    • Cushing's disease in children [ndash] the effectiveness and complications of transsphenoidal surgery

      ea0032p895
    • Effect of treatment outcome on co-morbidities of Cushing's disease

      ea0032p896
    • Serum GH but not IGF1 levels correlate with body composition parameters in both men and women with active acromegaly

      ea0032p897
    • Receptor expression in craniopharyngiomas causing tumor growth in pregnancy: case report and review of the literature

      ea0032p898
    • Increased thyroid cancer risk in acromegaly

      ea0032p900
    • Efficacy and safety of lanreotide in combination with pegvisomant in clinical practice in patients with active acromegaly with monotherapy failure

      ea0032p901
    • Efficacy and safety of lanreotide in combination with cabergoline in clinical practice in patients with active acromegaly with monotherapy failure

      ea0032p902
    • Efficacy of hGH treatment in pituitary dwarfism- age does matter

      ea0032p903
    • Clinical, hormonal and radiological characteristics of a group of primary empty sella patients

      ea0032p904
    • The effects of cabergoline treatment on cardiac valves in patients with prolactinoma

      ea0032p905
    • Treatment with pasireotide LAR normalizes prolactin levels in patients with acromegaly and hyperprolactinemia: randomized, double-blind, 12-month, phase III study

      ea0032p906
    • Characteristics and outcomes of the Italian subpopulation enrolled in the observational, multicenter hypopituitary control and complications study (HypoCCS)

      ea0032p907
    • Sleep-apnea and cardiomyopathy in acromegalic patients

      ea0032p908
    • PONV prophylaxis alters postoperative cortisol-measurement in transphenoidal pituitary surgery

      ea0032p909
    • Report of a new case of the novel AIP p.R314W mutation in a Romanian sporadic acromegaly patient

      ea0032p910
    • The p.R16H AIP sequence variant is relatively frequent in Romanian sporadic pituitary adenoma patients

      ea0032p911
    • Prevalance of cancer in acromegaly patients; a single center data

      ea0032p912
    • Comparison of insulin tolerance test and ACTH stimulation test for evaluation of hypocortisolism in patients with acromegaly

      ea0032p913
    • Functional hyperprolactinemia in polycystic ovary syndrome: incidence and correlation with hormonal parameters

      ea0032p914
    • Bone turnover decreases 6 months after acromegaly remission but still remains higher than in healthy population

      ea0032p915
    • Skin flora in acromegaly

      ea0032p916
    • Effect of short- and long-term treatment with pasireotide on hemochrome in patients with Cushing's disease

      ea0032p917
    • Evaluation of QT dispersion at the time of diagnosis and at the end of follow-up in acromegaly patients

      ea0032p918
    • Transsphenoidal surgery, gamma-knife surgery and diabetes are the factors affecting the quality of life in acromegalic patients

      ea0032p919
    • The short synacthen test may be more sensitive than the glucagon stimulation test in assessing the hypothalamic[ndash]pituitary[ndash]adrenal axis: a retrospective audit

      ea0032p920
    • Abstract unavailable

      ea0032p921
    • Characterization of GH-producing pituitary adenomas according to responsiveness to thyrotropin-releasing hormone

      ea0032p922
    • Tumour volume reduction and GH/IGF1 control with lanreotide Autogel 120 mg every 28 days for treatment-naive acromegalic patients with GH-secreting pituitary macroadenoma: the PRIMARYS study

      ea0032p923
    • Endoscopic transsphenoidal surgery for acromegaly: assessing the surgical outcome based on current criteria of remission

      ea0032p924
    • The influence of octreotide-LAR treatment on glucose homeostasis in acromegaly

      ea0032p925
    • Somatotropin and IGF1 levels at diagnose and after surgery in acromegalic patients: is it possible to predict the likelihood of cure at diagnosis?

      ea0032p926
    • Therapeutic response to recombinat somatropin in children with isolated deficiency of GH

      ea0032p927
    • Thyroid cancer in patients with acromegaly

      ea0032p928
    • Therapeutic role of dopamine-agonists in ESRF-induced hyperprolactinaemia

      ea0032p929
    • A rare case of pituitary infarction in an 11-year-old pre-pubertal girl with pituitary autoantibodies to piccolo

      ea0032p930
    • Idiopathic isolated ACTH deficiency presenting with severe hyponatraemia

      ea0032p931
    • Diagnostic features and surgical therapy of acromegalic patients: experience of the last three decades

      ea0032p932
    • Pituitary tumours and epilepsy

      ea0032p933
    • Predictors of hormonal status after pituitary surgery

      ea0032p934
    • Fetuin-A can be used as a marker of acromegaly

      ea0032p935
    • Evaluation of body weight, insulin resistance, leptin and adiponectin levels in premenopausal women with hyperprolactinemia

      ea0032p936
    • Carbohydrate metabolism in acromegaly and treatment impact

      ea0032p937
    • Pituitary apoplexy in clinically nonfunctioning pituitary adenomas: experience of a single center

      ea0032p938
    • Pituitary abscess: a possible cause of hypopituitarism

      ea0032p939
    • Cushing's disease recurrence after pregnancy

      ea0032p940
    • Clinical presentation, treatment approach and outcomes of patients with prolactinomas in real-life clinical practice: a single center experience

      ea0032p941
    • Clinical characteristics of patients with congenital hypopituitarism in advanced age

      ea0032p942
    • Pituitary abscess after cabergoline treatment of a prolactinoma in a 56 year old male: case report and review of the literature

      ea0032p943
    • Tuberous sclerosis: an uncommon cause of hyperprolactinemia

      ea0032p944
    • Hemiparesis and hemiplegia as clinical presentation in subjects with pituitary tumours

      ea0032p945
    • Relation with carotid intima media thickness and procalcitonin in acromegalic patients

      ea0032p946
    • The role of octreotide LAR treatment on BMI in patients with acromegaly

      ea0032p947
    • Effect of somatotropin and IGF1 secretion on glucose metabolism: diabetic ketoacidosis as first manifestation of acromegaly

      ea0032p948
    • Prolactinoma: does the size affect the signs?

      ea0032p949
    • Diagnosis and treatment of a population of acromegalic patients

      ea0032p950
    • Syndrome of inappropriate antidiuresis due to low dose hydrochlorothiazide use in a patient after transsphenoidal surgery for pituitary adenoma

      ea0032p951
    • An acromegalic patient with giant tumor

      ea0032p952
    • Hyperprolactinemia in women

      ea0032p953
    • Radiotherapy in the management of pituitary functioning adenomas: a single-center experience

      ea0032p954
    • Atypical McCune[ndash]Albright syndrome associated with GH secreting pituitary adenoma

      ea0032p955
    • Hyponatremia as a first sign of panhypopituitarism: empty sella

      ea0032p956
    • Somatotrop adenomas: comparison between men and women in algerian population

      ea0032p957
    • Non functionning pituitary adenomas

      ea0032p958
    • Assessment of bone mineral density in patients with Sheehan's syndrome

      ea0032p959
    • Giant invasive macroprolactinoma 2: case report

      ea0032p960
    • Pituitary hyperplasia secondary to primary hypothyroidism in a child with mosaic trisomy 21

      ea0032p961
    • Can apelin level used as a marker of active and inactive acromegaly?

      ea0032p962
    • Pasireotide in treatment of Cushing's disease: our first experience

      ea0032p963
    • Corticotroph adenoma and fertility

      ea0032p964
    • Central hypothyroidism and adjusted thyroxine dose study (CHATS): impact of increasing free thyroxine levels in patients with hypopituitarism

      ea0032p965
    • A retrospective-prospective study of the effect of octreotide LAR in acromegalic patients

      ea0032p966
    • Craneopahrygioma: a false enemy

      ea0032p967
  • Steroid metabolism and action
  • • Androgenic and estrogenic regulation of skeletal muscle mass and atrophy signaling in male mice

      ea0032p968
    • Cross-sex hormone therapy related adverse events: data from a large gender identity unit

      ea0032p969
    • Screening for Cushing's syndrome in obese patients

      ea0032p970
    • Role of retinol dehydrogenase 12 (RDH12) in the biosynthesis of 5[alpha]-androstane-3[beta],17[beta]-diol (3[beta]-diol) in the skin

      ea0032p971
    • Differences in adipose tissue lipolysis in critically ill septic patients with and without shock

      ea0032p972
    • UGT2B17 genotype and pharmacokinetic profile of testosterone during substitution therapy in men with hypogonadism

      ea0032p973
    • Effects of food components and the ratio of epitestosterone to testosterone on steroid glucuronidation

      ea0032p974
    • Impact of smoking on neuroactive steroids

      ea0032p975
    • Changes of steroidogenesis subject to weight growth

      ea0032p976
  • Thyroid (non-cancer)
  • • Determinants of between-subject variation in thyroid hormone status in healthy young men

      ea0032p977
    • Efficacy of treatment of cardiac complications in patients with Graves' disease

      ea0032p978
    • Pilot study of nocturnal TSH surge in idiopathic short stature

      ea0032p979
    • Is previous hyperthyroidism associated with long-term cognitive dysfunction? A twin study

      ea0032p980
    • The influence of single dose recombinant human thyroid-stimulating hormone on the efficacy of radioiodine therapy in patients with non toxic nodular goitre with low RAIU

      ea0032p981
    • PRIMARA: a prospective descriptive observational study to review cinacalcet use in patients with primary hyperparathyroidism in clinical practice

      ea0032p982
    • A comparative study evaluating the roles of inferior thyroid artery blood flow velocities measured by color flow Doppler ultrasonography, TSH receptor antibody and Tc-99m pertechnetate uptake for differential diagnosis between Graves' disease and silent thyroiditis

      ea0032p983
    • Both Graves' disease and toxic nodular goiter are associated with increased mortality but differ with respect to the cause of death: a Danish population-based register study

      ea0032p984
    • Efficacy and safety of combined parenenteral and oral steroid therapy in Graves' orbitopathy

      ea0032p985
    • Type and extent of morbidity before and after the diagnosis of hypothyroidism: a nationwide register-based study

      ea0032p986
    • Influence of thyrotropin on human peripheral blood immune cell populations

      ea0032p987
    • Hemithyroidectomy for benign euthyroid goiter increases the mitochondrial membrane potential of peripheral mononuclear blood cells

      ea0032p988
    • Influence of smoking on hyperthyroidism severity in newly diagnosed Graves' disease patients

      ea0032p989
    • Postprandial studies uncover differing effects on HDL particles of overt and subclinical hypothyroidism

      ea0032p990
    • Quantification of tissue T3 and T4 in rat and human heart by a novel HPLC-MS/MS method

      ea0032p991
    • Study on linear growth and thyroid function for 12 years in patients with [beta] thalassemia major

      ea0032p992
    • Levothyroxine requirements in thyroidectomized diabetic patients receiving metformin

      ea0032p993
    • Association between the use of computed tomography scans using iodine-based contrast medium and the development of subsequent hyperthyroidism

      ea0032p994
    • Metformin decreases thyroid volume and nodule size in subjects with insulin resistance

      ea0032p995
    • A case of severe hypoglycaemia in a patient with hyperthyroidism

      ea0032p996
    • Associations between urinary phthalate metabolites and thyroid function: pilot study

      ea0032p997
    • Selective embolization of thyroid arteries (SETA) in patients with Graves' disease

      ea0032p998
    • Short-term effects of thyroid hormone therapy on quality-of-life evaluation by ThyPRO questionnaire in chronic autoimmune thyroiditis

      ea0032p999
    • Genetic examination of the TSHR gene in patients with congenital hypothyroidism: systematic survey of a Hungarian cohort

      ea0032p1000
    • In pregnant women receiving levothyroxine, higher 3rd trimester TSH and maternal underweight are associated with cesarean section due to foetal malposition

      ea0032p1001
    • Diagnosis of hypothyroidism is associated to an increased risk of acute decompensated heart failure occurrence, but not of mortality among heart failure outpatients

      ea0032p1002
    • Thyroid-stimulating hormone and insulin resistance indexes in women with polycystic ovary syndrome

      ea0032p1003
    • Overweight/obese women with primary acquired hypothyroidism in appropriate levothyroxine replacement therapy are characterized by impaired whole body energy metabolism

      ea0032p1004
    • TSH-deficiency is associated with a lower thyroid gland volume in hypopituitaric patients compared to healthy volunteers: a cross-sectional study

      ea0032p1005
    • Prevalance of GH deficiency in Turkish patients with Hashimoto's thyroiditis: a single center experience

      ea0032p1006
    • Insulin resistance in patients with thyroid dysfunction and hepatosteatosis

      ea0032p1007
    • Vitamin D status in autoimmune hypothyroidism

      ea0032p1008
    • Vascular endothelial growth factor and granulocyte[ndash]monocyte colony stimulating factor levels in nodular thyroid diseases

      ea0032p1009
    • Increased TRAb and/or low anti-TPO titers at diagnosis of Graves' disease (GD) are associated with an increased risk of developing ophthalmopathy after onset of GD

      ea0032p1010
    • Latent toxoplasmosis: a novel risk factor for autoimmune thyroid diseases in pregnancy?

      ea0032p1011
    • Iodine status in women after early miscarriages in the Czech Republic

      ea0032p1012
    • An open-label, randomized, controlled study of the effectiveness and safety of a high intensity focused ultrasound device compared with observation in patients with non-malignant cold thyroid nodules

      ea0032p1013
    • Biochemical testing on wide indication to detect overt hypothyroidism is justified: a population-based case[ndash]control study in patients newly diagnosed with overt autoimmune hypothyroidism

      ea0032p1014
    • Associations of (F)T3 and the ratio FT3:FT4 with a cluster of obesity-related cardiovascular risk markers in healthy euthyroid middle-aged men and women

      ea0032p1015
    • Evaluation of hemostatic parameters in patients with Hashimoto's thyroiditis

      ea0032p1016
    • Comparison of hs-CRP and Fetuine-A levels before and after the treatment of subjects with subclinical hyperthyroidism

      ea0032p1017
    • Thyroid morphofunctional parameters in amiodarone induced thyrotoxicosis compared to endogenous hyperthyroidism

      ea0032p1018
    • Differential item functioning of the thyroid-specific quality of life questionnaire ThyPRO

      ea0032p1019
    • Insulin resistance in patients with hypothyroidism or hyperthyroidism without hepatosteatosis

      ea0032p1020
    • Should subclinical hypothyroidism diagnosed during pregnancy be treated with long-term L-thyroxine?

      ea0032p1021
    • IgG4-related Hashimoto's thyroiditis: an emerging variant of a well known disease

      ea0032p1022
    • Prevalence of thyroiditis in ankylosing spondylitis patients

      ea0032p1023
    • The study of gastrointestinal hormones in patients with hypothyroidism of middle-aged and elderly

      ea0032p1024
    • The study of levels erythropoietin and proinflammatory cytokines in patients with hypothyroidism of different ages

      ea0032p1025
    • Acute renal failure as the first presentation of severe hypothyroidism

      ea0032p1026
    • Thyroid diffuse lipomatosis: a rare and benign disease

      ea0032p1027
    • Regression of ophthalmopathic exophthalmos in Graves' disease after thyroidectomy: an observational study in a surgical series

      ea0032p1028
    • Vitamin E supplementation in the treatment of Graves' disease

      ea0032p1029
    • Radioiodine treatment of hyperthyroidism in the elderly

      ea0032p1030
    • The influence of subclinical hypothyroidism on glucose levels

      ea0032p1031
    • Coexistent toxic adenoma and Riedel thyroiditis: a case report

      ea0032p1032
    • Internal jugular vein thrombosis and intensely hypermetabolic thyroid on 18F-FDG PET/CT

      ea0032p1033
    • Comparison of pre- and post-levothyroxine hs-CRP and fetuin-A levels in subclinical hypothyroidism

      ea0032p1034
    • The natural history of subclinical hyperthyroidism: a single centre experience

      ea0032p1035
    • Morpho-functional features of rabbit's thyroid gland with its autotransplantation in the thigh muscle

      ea0032p1036
    • Sexual dysfunction in women with thyroid pathology

      ea0032p1037
    • Relationship of benign thyroid disorders with histological alterations of breast tissue. (Preliminary results of an observational study conducted in Greece)

      ea0032p1038
    • Clinical outcomes in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine

      ea0032p1039
    • Thyroid hormone elevates IL6 tissues content and causes hypoleptinemia

      ea0032p1040
    • The determination of nitric oxide levels in treatment-na[iuml]ve hypothyroid females: pilot study

      ea0032p1041
    • Haemodialysis-induced changes in thyroid hormones and thyrotropin

      ea0032p1042
    • Simultaneous occurrence of hyperthyroid and hyperglycemic emergency in a middle aged woman

      ea0032p1043
    • Immune associations in chronic thyroiditis: December 2012

      ea0032p1044
    • Graves' disease and cardiovascular risk factors

      ea0032p1045
    • Thyroid dysfunction in type 2 diabetic patients

      ea0032p1046
    • Clinical and subclinical hypothyroidism and their relation to cardiovascular risk factors

      ea0032p1047
    • The usefulness of thyroid function test in patients presenting with symptomatic bradycardia/complete heart block

      ea0032p1048
    • Subacute thyroiditis: unusual presentation and diagnostic troubles

      ea0032p1049
    • Simplified approach for the treatment of post-thyroidectomy hypocalcemia: a Pilot study

      ea0032p1050
    • The influence of thyroid hormones on the variability of blood pressure

      ea0032p1051
    • Serum concentrations of cholesterol and triglyceride in patients with type 2 diabetes and incident hypothyroidism

      ea0032p1052
    • The characteristics of thyroid pathology in patients with parathyroid adenoma

      ea0032p1053
    • Learning and development of thyroid FNA in a endocrine clinic

      ea0032p1054
    • Does a normal thyroid ultrasound image always accompany normal thyroid functions test results?

      ea0032p1055
    • The cholesterol and Lp(a) levels in Hashimato's thyroiditis

      ea0032p1056
    • Comprehensive assessment of thyroid gland structure and function in men with metabolic syndrome

      ea0032p1057
    • Empirical calcium supplements paves way for day surgery complete thyroidectomy

      ea0032p1058
    • Is TSH suppression an efficient thyroid nodular goitre therapy?

      ea0032p1059
    • Correlation between untreated subclinical hypothyroidism, nephropathy and cardiovascular diseases in type 2 diabetic patients

      ea0032p1060
    • Relationships between antithyroperoxydase antibody levels, thyroid function and echographic patterns in chronic thyroiditis: December 2012

      ea0032p1061
    • Ten ultrasonographic thyroid pattern in Hashimoto's thyroiditis: re-evaluation after 12 years

      ea0032p1062
    • Superior vena cava syndrome due to enlarged thyroid gland

      ea0032p1063
    • The change of character in passing of Graves' disease in St Petersburg from 1970 to 2010

      ea0032p1064
    • Subclinical autoimmune thyroid disease and cardiovascular risk factors

      ea0032p1065
    • Subclinical hypothyroidism, autoimmune thyroiditis, and cardiovascular risk factors

      ea0032p1066
    • Marine[ndash]lenhart syndrome

      ea0032p1067
    • Is Hashimoto's thyroiditis in children different from adults? A prospective comparative study

      ea0032p1068
    • Evolution of thyroid function in Hashimoto thyroiditis and related disorders: December 2012

      ea0032p1069
    • Abstract unavailable

      ea0032p1070
    • Autoimmune hypo to hyperthyroidism: a rare evolution

      ea0032p1071
    • The cause of haematoma on the anterior neck

      ea0032p1072
    • Acute respiratory failure in a rapidly-enlarging benign cervical goiter

      ea0032p1073
    • Vitiligo: anti-thyroid peroxidase antibody

      ea0032p1074
    • Protective antioxidative effects of caffeic acid phenethyl ester in the thyroid and the liver are similar to those caused by melatonin

      ea0032p1075
    • Use of scintigraphy in the current diagnosis of thyroid diseases

      ea0032p1076
  • Thyroid cancer
  • • Association acromegaly and thyroid cancer

      ea0032p1077
    • Double primary carcinoma [ndash] a case of coexisting papillary thyroid carcinoma and pulmonary adenocarcinoma

      ea0032p1078
    • Rac1B: a prognostic marker for papillary thyroid carcinoma?

      ea0032p1079
    • A single-center, open-label, phase II, proof-of-concept study with pasireotide long-acting release in patients with progressive medullary thyroid cancer: 6-month evaluation

      ea0032p1080
    • A novel multi-target pyrazolopyrimidine derivative with anti-neoplastic properties, CLM29, is active against medullary thyroid cancer in vitro and in vivo

      ea0032p1081
    • Association of pre-miR-146a rs2910164 GG genotype with papillary thyroid cancer: a new case[ndash]control study on two adjacent genes on chromosome 5, pre-miR-146a and PTTG1.

      ea0032p1082
    • Circulating microRNAs may help to differentiate malignant from benign thyroid nodules

      ea0032p1083
    • Inhibition of proliferation in anaplastic thyroid cell lines

      ea0032p1084
    • Pre-existing autoimmune thyroid disease may influence the course of the disease in differentiated thyroid carcinoma patients

      ea0032p1085
    • Evaluation of treatment approaches to the sporadic and hereditary medullary thyroid carcinoma in Turkey

      ea0032p1086
    • Sentinel lymph node biopsy in thyroid carcinoma and decision for selective modified radical neck dissection

      ea0032p1087
    • Pre-miR146a expression profiling of follicular thyroid carcinoma

      ea0032p1088
    • 68Ga-DOTA-NOC PET/CT role in the follow-up of patients with medullary thyroid carcinoma

      ea0032p1089
    • Distribution of ret proto-oncogene mutations among Turkish familial medullary thyroid cancer/multiple endocrine neoplasia 2 patients

      ea0032p1090
    • Treating refractory thyroid cancer in the era of multitarget tyrosine kinase inhibitors

      ea0032p1091
    • Mutations and somatic changes in the genotype of rs2910164 in pre-miR146a are frequent in follicular thyroid carcinoma

      ea0032p1092
    • Interobserver agreement of thyroid imaging reporting and data system and realtime elastography for the assessment of thyroid nodules

      ea0032p1093
    • Medullary thyroid carcinoma [ndash] a narrow surgical window

      ea0032p1094
    • Prognostic value of postoperative thyroglobulin levels for papillary thyroid carcinoma

      ea0032p1095
    • Radioactive iodine therapy in papillary thyroid carcinomas staged as T1

      ea0032p1096
    • The role of radioiodine SPECT/CT in differentiated thyroid cancer

      ea0032p1097
    • Examination of CYP24A1 and 'three-genes' (SFN, MRC2, HMGA2) expressions in different pathological subgroups of human papillary thyroid cancer

      ea0032p1098
    • The prevalence, the tumorigenic role and the functional implications of rare BRAF alterations in a cohort of Italian patients with thyroid carcinomas

      ea0032p1099
    • Thyroglobulin in fine-needle aspiration wash-out diagnostic performance: a meta-analysis

      ea0032p1100
    • Thyroglobulin levels in the washout of lymph node fine-needle aspirate on patients with previous history of differentiated thyroid cancer

      ea0032p1101
    • The diagnostic accuracy of ultrasound-guided fine needle aspiration biopsy (FNAB) in thyroid nodules 3 cm and above in size and sonographic feature differences between malignant and benign nodules

      ea0032p1102
    • Evaluation of whole-body scan, stimulated thyroglobulin after thyroxine withdrawal vs recombinant TSH administration according to the risk groups of tumor recurrence

      ea0032p1103
    • Stimulated serum Tg [ge]0.285 ng/ml in anti-Tg([minus]) cases had 3.087 times increased likelihood of recurrence of differentiated thyroid cancer: a single center experience

      ea0032p1104
    • Papillary thyroid carcinoma with focal hobnail features

      ea0032p1105
    • Serum calcitonin, thyrotropin, and goiter

      ea0032p1106
    • Incidental thyroid cancer frequency in total thyroidectomy for the graves disease patients and the effect of the presence of nodules on malignity rates

      ea0032p1107
    • Detecting somatic oncogene mutations in FNA samples of cold nodules in Hungary

      ea0032p1108
    • Predictive value of preablation stimulated thyroglobulin in differentiated thyroid cancer

      ea0032p1109
    • Concurrent follicular and columnar cell variants of papillary thyroid carcinoma characterized by different BRAF status and metastatic properties: a case review

      ea0032p1110
    • Thyroglobulin as an early marker of persistent/recurrent disease in patients with differentiated thyroid carcinoma (DTC)

      ea0032p1111
    • Ultrasound guided enolization as a therapeutic alternative in local recurrences of papillary thyroid carcinoma

      ea0032p1112
    • Liquid preparation cytology for evaluation of thyroid nodules

      ea0032p1113
    • Prevalence of hypovitaminosis D in patients with papillary thyroid carcinoma (PTC)

      ea0032p1114
    • Primary thyroid lymphoma [ndash] report of four cases

      ea0032p1115
    • Treatment, follow up and prognostic factors of papillary microcarcinoma

      ea0032p1116
    • Macrofollicular variant of papillary thyroid carcinoma: an uncommon entity

      ea0032p1117
    • Postoperative stimulated thyroglobulin levels in thyroidectomized patients with differentiated thyroid cancer

      ea0032p1118
    • Angiosarcoma of the thyroid gland: a case report

      ea0032p1119
    • MIBI [ndash] spect scintigraphy in the presurgical assessment of thyroid lesions with indeterminate cytology

      ea0032p1120
    • Clinical and biochemical criteria for the prognosis of small medullary thyroid carcinomas

      ea0032p1121
    • Diagnostic validity of thyroid ultrasonography in thyroid nodules

      ea0032p1122
    • Histopathologic characterization of differentiated thyroid carcinoma in an area of Basque country

      ea0032p1123
    • A rare case of nonsecretory medullary thyroid carcinoma

      ea0032p1124
    • Coexistent medullary thyroid carcinoma and multifocal papillary thyroid microcarcinoma in a patient with chronic autoimmune thyroiditis

      ea0032p1125
    • BRAF V600E mutation in papillary thyroid cancer: clinical and pathological features. Is there any role in tailoring initial treatment?

      ea0032p1126
    • A case of papillary thyroid carcinoma in a patient with familial adenomatous polyposis of the colon

      ea0032p1127
    • Metastatic papillary thyroid carcinoma arising from thyroglossal duct cyst

      ea0032p1128
    • Thyroid cancer frequency in acromegalic subjects

      ea0032p1129
    • Poor prognosis of recurrent and persistent papillary thyroid carcinoma with high anti-thyroglobulin antibody titers

      ea0032p1130
    • Well differentiated thyroid-type carcinoma arising from struma ovarii a report of two cases

      ea0032p1131
    • Male patient with neck mass: ectopic cancer vs metastasic disease

      ea0032p1132
    • Papillary carcinoma with diffuse toxic guatr and highly resistant course

      ea0032p1133
    • Brain metastases of papillary thyroid cancer: a case report and literature review

      ea0032p1134
    • Choroidal bilateral metastases from thyroid carcinoma: report of a case and review of the literature

      ea0032p1135
    • Thyroglobulin measurement in fine needle aspirates from cervical lymph nodes

      ea0032p1136
    • Poorly differentiated thyroid carcinoma: a clinicopathologic study of 30 cases

      ea0032p1137
    • Adrenal metastases from thyroid cancers

      ea0032p1138
    • Thyroid papillary carcinoma in a toxic adenoma: case report

      ea0032p1139
    • Ultrasonographic signs suggestive of malignancy in thyroid nodules

      ea0032p1140